(+)-pilocarpine increases activity ISO RGD:731911 6480464 Pilocarpine results in increased activity of MMP9 protein CTD PMID:19631748 (+)-pilocarpine increases expression ISO RGD:731911 6480464 Pilocarpine results in increased expression of MMP9 protein CTD PMID:19631748 (+)-Pimaric acid multiple interactions ISO RGD:1348437 6480464 pimaric acid inhibits the reaction [TNF protein results in increased expression of and results in increased activity of MMP9 protein], pimaric acid inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] CTD PMID:22705379 (+)-Tetrandrine multiple interactions EXP 6480464 tetrandrine inhibits the reaction [IL1B protein results in increased expression of and results in increased activity of MMP9 protein] CTD PMID:22001142 (+)-Tetrandrine decreases expression ISO RGD:1348437 6480464 tetrandrine results in decreased expression of MMP9 protein CTD PMID:30549224 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:731911 6480464 epigallocatechin gallate inhibits the reaction [Toluene 2 more ... CTD PMID:16516891 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1348437 6480464 epigallocatechin gallate inhibits the reaction [Particulate Matter results in increased expression of MMP9 protein] CTD PMID:31252129 (-)-epigallocatechin 3-gallate decreases activity ISO RGD:731911 6480464 epigallocatechin gallate results in decreased activity of MMP9 protein CTD PMID:11746506 (24S)-24-hydroxycholesterol increases expression ISO RGD:1348437 6480464 24-hydroxycholesterol results in increased expression of MMP9 mRNA CTD PMID:24802026 (24S)-24-hydroxycholesterol multiple interactions ISO RGD:1348437 6480464 Quercetin analog inhibits the reaction [24-hydroxycholesterol results in increased expression of MMP9 mRNA] CTD PMID:24802026 (25R)-cholest-5-ene-3beta,26-diol increases expression ISO RGD:1348437 6480464 27-hydroxycholesterol results in increased expression of MMP9 mRNA CTD PMID:24802026 (25R)-cholest-5-ene-3beta,26-diol multiple interactions ISO RGD:1348437 6480464 Quercetin analog inhibits the reaction [27-hydroxycholesterol results in increased expression of MMP9 mRNA] CTD PMID:24802026 (R)-carnitine multiple interactions EXP 6480464 Carnitine inhibits the reaction [sunitinib results in decreased expression of MMP9 mRNA] CTD PMID:26581635 (R)-mevalonic acid multiple interactions ISO RGD:1348437 6480464 Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased secretion of MMP9 protein]], Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]] CTD PMID:15728660 (R)-noradrenaline increases expression ISO RGD:1348437 6480464 Norepinephrine results in increased expression of MMP9 mRNA CTD PMID:24929186 (R)-noradrenaline increases expression EXP 6480464 Norepinephrine results in increased expression of MMP9 mRNA CTD PMID:16864425 (R)-noradrenaline increases activity EXP 6480464 Norepinephrine results in increased activity of MMP9 protein CTD PMID:16864425 (R)-noradrenaline multiple interactions EXP 6480464 crocetin inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA] CTD PMID:16864425 (R)-noradrenaline increases activity ISO RGD:1348437 6480464 Norepinephrine results in increased activity of MMP9 protein CTD PMID:24929186 (R)-noradrenaline multiple interactions ISO RGD:1348437 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA] more ... CTD PMID:24929186 (S)-naringenin multiple interactions ISO RGD:1348437 6480464 naringenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] more ... CTD PMID:25866363 , PMID:30431227 (S)-naringenin decreases expression ISO RGD:1348437 6480464 naringenin results in decreased expression of MMP9 mRNA CTD PMID:30153467 (S)-nicotine increases expression ISO RGD:1348437 6480464 Nicotine results in increased expression of MMP9 mRNA, Nicotine results in increased expression of MMP9 protein CTD PMID:14569062 , PMID:20061081 (S)-nicotine multiple interactions ISO RGD:1348437 6480464 MK-886 inhibits the reaction [Nicotine results in increased expression of MMP9 mRNA] CTD PMID:20061081 (S)-nicotine decreases expression ISO RGD:731911 6480464 Nicotine results in decreased expression of MMP9 protein CTD PMID:20448088 1'-acetoxychavicol acetate multiple interactions ISO RGD:1348437 6480464 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of MMP9 protein] CTD PMID:15905586 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane multiple interactions EXP 6480464 2 more ... CTD PMID:16378139 , PMID:16683234 1,10-phenanthroline multiple interactions ISO RGD:731911 6480464 1, 10-phenanthroline inhibits the reaction [PLAU protein results in increased activity of MMP9 protein] CTD PMID:20177776 1,10-phenanthroline multiple interactions EXP 6480464 1, 10-phenanthroline inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein] CTD PMID:20195827 1,2,3-Trichloropropane increases expression ISO RGD:1348437 6480464 1 more ... CTD PMID:22952646 1,2-dichloroethane increases expression ISO RGD:731911 6480464 ethylene dichloride results in increased expression of MMP9 mRNA, ethylene dichloride results in increased expression of MMP9 protein CTD PMID:24964198 , PMID:30081051 1,2-dichloroethane multiple interactions ISO RGD:731911 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [ethylene dichloride results in increased expression of MMP9 mRNA], 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [ethylene dichloride results in increased expression of MMP9 protein] CTD PMID:30081051 1,2-dimethylhydrazine multiple interactions EXP 6480464 artesunate inhibits the reaction [1 more ... CTD PMID:29031619 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of MMP9 protein CTD PMID:29031619 1,3-benzothiazole-2-thiol increases expression ISO RGD:1348437 6480464 captax results in increased expression of MMP9 mRNA, captax results in increased expression of MMP9 protein CTD PMID:22952646 1-naphthyl isothiocyanate multiple interactions ISO RGD:1348437 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of MMP9 mRNA CTD PMID:27344345 1-octadec-9-enoylglycero-3-phosphate increases expression ISO RGD:1348437 6480464 lysophosphatidic acid results in increased expression of MMP9 mRNA CTD PMID:23127547 1-octadec-9-enoylglycero-3-phosphate multiple interactions ISO RGD:1348437 6480464 gefitinib inhibits the reaction [lysophosphatidic acid results in increased expression of MMP9 mRNA] more ... CTD PMID:23127547 15-deoxy-Delta(12,14)-prostaglandin J2 decreases expression ISO RGD:731911 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in decreased expression of MMP9 mRNA CTD PMID:19997048 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions ISO RGD:731911 6480464 15-deoxy-delta(12 more ... CTD PMID:19997048 17alpha-ethynylestradiol decreases expression ISO RGD:731911 6480464 Ethinyl Estradiol results in decreased expression of MMP9 mRNA, Ethinyl Estradiol results in decreased expression of MMP9 protein CTD PMID:12538720 , PMID:30675821 17alpha-ethynylestradiol increases expression ISO RGD:731911 6480464 Ethinyl Estradiol results in increased expression of MMP9 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:731911 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MMP9 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:731911 6480464 Ethinyl Estradiol affects the expression of MMP9 mRNA CTD PMID:17555576 17beta-estradiol multiple interactions ISO RGD:1348437 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased expression of MMP9 protein] more ... CTD PMID:17404688 more ... 17beta-estradiol increases activity ISO RGD:1348437 6480464 Estradiol results in increased activity of MMP9 protein CTD PMID:31468104 17beta-estradiol increases expression ISO RGD:1348437 6480464 Estradiol results in increased expression of MMP9 mRNA, Estradiol results in increased expression of MMP9 protein CTD PMID:12948864 more ... 17beta-estradiol increases expression ISO RGD:731911 6480464 Estradiol results in increased expression of MMP9 mRNA CTD PMID:19416213 17beta-estradiol multiple interactions ISO RGD:731911 6480464 Progesterone inhibits the reaction [Estradiol results in increased expression of MMP9 mRNA] CTD PMID:19416213 17beta-estradiol decreases expression ISO RGD:1348437 6480464 Estradiol results in decreased expression of MMP9 mRNA, Estradiol results in decreased expression of MMP9 protein CTD PMID:19956873 , PMID:21760532 17beta-estradiol decreases activity ISO RGD:1348437 6480464 Estradiol results in decreased activity of MMP9 protein CTD PMID:21760532 17beta-estradiol increases secretion ISO RGD:1348437 6480464 Estradiol results in increased secretion of MMP9 protein CTD PMID:20951759 17beta-estradiol increases activity ISO RGD:731911 6480464 Estradiol results in increased activity of MMP9 protein CTD PMID:19279558 2,2',4,4'-Tetrabromodiphenyl ether decreases secretion ISO RGD:1348437 6480464 2 more ... CTD PMID:32142752 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1348437 6480464 2 more ... CTD PMID:32142752 2,2'-bipyridine increases activity ISO RGD:1348437 6480464 2, 2'-Dipyridyl results in increased activity of MMP9 protein CTD PMID:18674879 2,2'-bipyridine multiple interactions ISO RGD:1348437 6480464 resveratrol inhibits the reaction [2, 2'-Dipyridyl results in increased activity of MMP9 protein] CTD PMID:18674879 2,2'-bipyridine increases expression ISO RGD:1348437 6480464 2, 2'-Dipyridyl results in increased expression of MMP9 mRNA CTD PMID:18674879 2,2,2-trichloroethanol increases activity ISO RGD:1348437 6480464 2 more ... CTD PMID:21741468 2,2,2-trichloroethanol increases expression ISO RGD:1348437 6480464 2 more ... CTD PMID:21741468 2,3,3',4,4',5,5'-Heptachlorobiphenyl decreases expression ISO RGD:1348437 6480464 2 more ... CTD PMID:26238599 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1348437 6480464 JUN protein affects the reaction [Tetrachlorodibenzodioxin results in increased activity of MMP9 protein] more ... CTD PMID:15982688 more ... 2,3,7,8-tetrachlorodibenzodioxine affects binding ISO RGD:1348437 6480464 Tetrachlorodibenzodioxin binds to MMP9 protein CTD PMID:32278787 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MMP9 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731911 6480464 Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA CTD PMID:17586704 more ... 2,3,7,8-tetrachlorodibenzodioxine increases activity ISO RGD:731911 6480464 Tetrachlorodibenzodioxin results in increased activity of MMP9 protein CTD PMID:24154488 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:731911 6480464 Tetrachlorodibenzodioxin affects the expression of MMP9 mRNA CTD PMID:21570461 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731911 6480464 [Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of MMP9 mRNA more ... CTD PMID:17942748 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1348437 6480464 Tetrachlorodibenzodioxin results in increased expression of MMP9, Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA CTD PMID:12377990 more ... 2,3,7,8-tetrachlorodibenzodioxine increases activity ISO RGD:1348437 6480464 Tetrachlorodibenzodioxin results in increased activity of MMP9 protein CTD PMID:15922868 more ... 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 4-methylesculetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of MMP9 protein] more ... CTD PMID:22119283 2,4-diaminotoluene increases expression ISO RGD:731911 6480464 2, 4-diaminotoluene results in increased expression of MMP9 mRNA CTD PMID:20713471 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of MMP9 mRNA CTD PMID:18678246 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO RGD:1348437 6480464 Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] more ... CTD PMID:17498959 , PMID:19375915 2-amino-2-deoxy-D-glucopyranose increases expression EXP 6480464 Glucosamine results in increased expression of MMP9 mRNA CTD PMID:17109745 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of MMP9 mRNA], IL1B affects the reaction [Glucosamine results in increased expression of MMP9 mRNA] CTD PMID:17109745 2-Amino-5-nitrophenol increases expression ISO RGD:1348437 6480464 2-amino-5-nitrophenol results in increased expression of MMP9 mRNA, 2-amino-5-nitrophenol results in increased expression of MMP9 protein CTD PMID:22952646 2-deoxy-D-glucose decreases expression ISO RGD:1348437 6480464 Deoxyglucose analog results in decreased expression of MMP9 protein CTD PMID:27931795 2-methoxy-1,4-naphthoquinone decreases activity ISO RGD:1348437 6480464 2-methoxy-1, 4-naphthoquinone results in decreased activity of MMP9 protein CTD PMID:24291160 2-trans,6-trans,10-trans-geranylgeranyl diphosphate multiple interactions ISO RGD:1348437 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased expression of MMP9 mRNA]] more ... CTD PMID:15728660 2-trans,6-trans,10-trans-geranylgeranyl diphosphate multiple interactions EXP 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]] more ... CTD PMID:19299917 2-trans,6-trans-farnesyl diphosphate multiple interactions EXP 6480464 farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]], farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]] CTD PMID:19299917 26-hydroxycholesterol multiple interactions ISO RGD:1348437 6480464 Quercetin analog inhibits the reaction [27-hydroxycholesterol results in increased expression of MMP9 mRNA] CTD PMID:24802026 26-hydroxycholesterol increases expression ISO RGD:1348437 6480464 27-hydroxycholesterol results in increased expression of MMP9 mRNA CTD PMID:24802026 3,3',4,4',5-pentachlorobiphenyl affects expression ISO RGD:1348437 6480464 3 more ... CTD PMID:21703328 3,3',4,4',5-pentachlorobiphenyl increases secretion ISO RGD:731911 6480464 3 more ... CTD PMID:27663891 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1348437 6480464 3 more ... CTD PMID:27663891 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:731911 6480464 3 more ... CTD PMID:28973532 3,3',5,5'-tetrabromobisphenol A multiple interactions ISO RGD:1348437 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [tetrabromobisphenol A results in increased expression of MMP9 mRNA] more ... CTD PMID:30766661 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1348437 6480464 tetrabromobisphenol A results in increased expression of MMP9 mRNA CTD PMID:30766661 3,3'-diindolylmethane multiple interactions ISO RGD:1348437 6480464 3 more ... CTD PMID:25794856 , PMID:28844962 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions ISO RGD:1348437 6480464 MK-886 inhibits the reaction [Nicotine results in increased expression of MMP9 mRNA] CTD PMID:20061081 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions ISO RGD:731911 6480464 MK-886 inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein] CTD PMID:19837106 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions ISO RGD:1348437 6480464 bisindolylmaleimide I inhibits the reaction [HGF protein results in increased expression of MMP9 mRNA] more ... CTD PMID:12745093 more ... 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:731911 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA, TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA] CTD PMID:23503329 3-methyladenine multiple interactions ISO RGD:1348437 6480464 3-methyladenine inhibits the reaction [Hydrogen Peroxide results in decreased expression of MMP9 protein], 3-methyladenine inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]] CTD PMID:24145604 , PMID:32043704 3-methylcholanthrene multiple interactions ISO RGD:731911 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MMP9 mRNA CTD PMID:23519560 3-methylcholanthrene decreases expression ISO RGD:731911 6480464 Methylcholanthrene results in decreased expression of MMP9 mRNA CTD PMID:29554273 4,4'-sulfonyldiphenol multiple interactions ISO RGD:731911 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of and results in increased secretion of and results in increased activity of MMP9 protein CTD PMID:28903498 4,4'-sulfonyldiphenol increases expression ISO RGD:731911 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of MMP9 mRNA CTD PMID:30951980 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one decreases expression ISO RGD:731911 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MMP9 mRNA CTD PMID:21167638 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO RGD:731911 6480464 [Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of MMP9 mRNA CTD PMID:21167638 4-hydroxynon-2-enal decreases expression ISO RGD:731911 6480464 4-hydroxy-2-nonenal results in decreased expression of MMP9 mRNA CTD PMID:19191707 4-hydroxynon-2-enal increases activity ISO RGD:731911 6480464 4-hydroxy-2-nonenal results in increased activity of MMP9 protein CTD PMID:19837106 4-hydroxynon-2-enal multiple interactions ISO RGD:731911 6480464 ALOX5 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein] more ... CTD PMID:19837106 4-hydroxynon-2-enal increases expression ISO RGD:731911 6480464 4-hydroxy-2-nonenal results in increased expression of MMP9 mRNA, 4-hydroxy-2-nonenal results in increased expression of MMP9 protein CTD PMID:19191707 , PMID:19837106 4-hydroxyphenyl retinamide multiple interactions ISO RGD:1348437 6480464 Fenretinide inhibits the reaction [TNF protein results in increased expression of MMP9 protein] CTD PMID:16230421 4-hydroxyphenyl retinamide increases expression ISO RGD:731911 6480464 Fenretinide results in increased expression of MMP9 mRNA CTD PMID:28973697 4-nitroquinoline N-oxide increases expression ISO RGD:731911 6480464 4-Nitroquinoline-1-oxide results in increased expression of MMP9 mRNA CTD PMID:22561872 5,6alpha-epoxy-5alpha-cholestan-3beta-ol increases expression EXP 6480464 cholesterol alpha-oxide results in increased expression of MMP9 mRNA CTD PMID:20466046 5-(1,4-diazepane-1-sulfonyl)isoquinoline affects expression ISO RGD:731911 6480464 fasudil affects the expression of MMP9 mRNA CTD PMID:26120273 5-aza-2'-deoxycytidine increases expression ISO RGD:731911 6480464 Decitabine results in increased expression of MMP9 mRNA CTD PMID:27915011 5-aza-2'-deoxycytidine multiple interactions ISO RGD:731911 6480464 Decitabine inhibits the reaction [[bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of MMP9 mRNA] CTD PMID:29718165 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1348437 6480464 Decitabine inhibits the reaction [sodium arsenite results in increased expression of MMP9 mRNA], Decitabine inhibits the reaction [sodium arsenite results in increased expression of MMP9 protein] CTD PMID:21167264 5-azacytidine multiple interactions ISO RGD:1348437 6480464 metacept-1 inhibits the reaction [Azacitidine results in increased expression of MMP9] CTD PMID:19148494 5-chloro-7-iodoquinolin-8-ol multiple interactions ISO RGD:731911 6480464 Clioquinol inhibits the reaction [MOG protein results in increased activity of MMP9 protein] CTD PMID:23360710 5-fluorouracil affects expression ISO RGD:1348437 6480464 Fluorouracil affects the expression of MMP9 mRNA CTD PMID:15205334 5-fluorouracil increases expression ISO RGD:1348437 6480464 Fluorouracil results in increased expression of MMP9 protein CTD PMID:26310874 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions ISO RGD:1348437 6480464 6-chloro-2 more ... CTD PMID:24145604 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of MMP9 mRNA CTD PMID:24780913 7,12-dimethyltetraphene multiple interactions EXP 6480464 [9 more ... CTD PMID:12208745 , PMID:31332895 7,12-dimethyltetraphene affects expression ISO RGD:731911 6480464 9 more ... CTD PMID:21785161 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:12208745 7-ketocholesterol increases expression EXP 6480464 7-ketocholesterol results in increased expression of MMP9 mRNA CTD PMID:20466046 7-ketocholesterol multiple interactions ISO RGD:1348437 6480464 resveratrol inhibits the reaction [7-ketocholesterol results in increased expression of MMP9 protein] CTD PMID:24895526 7-ketocholesterol increases expression ISO RGD:1348437 6480464 7-ketocholesterol results in increased expression of MMP9 protein CTD PMID:24895526 7-NITROINDAZOLE multiple interactions ISO RGD:731911 6480464 [7-nitroindazole results in decreased activity of NOS1 protein] inhibits the reaction [[Morphine co-treated with Naloxone] results in increased activity of MMP9 protein] CTD PMID:20519536 7alpha-hydroxycholesterol multiple interactions ISO RGD:1348437 6480464 Quercetin analog inhibits the reaction [cholest-5-en-3 beta, 7 alpha-diol results in increased expression of MMP9 mRNA] CTD PMID:24802026 7alpha-hydroxycholesterol increases expression ISO RGD:1348437 6480464 cholest-5-en-3 beta, 7 alpha-diol results in increased expression of MMP9 mRNA CTD PMID:24802026 [6]-Shogaol multiple interactions ISO RGD:1348437 6480464 shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of MMP9 protein], shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] CTD PMID:23899529 abacavir increases expression ISO RGD:1348437 6480464 abacavir results in increased expression of MMP9 protein CTD PMID:19891054 acetaldehyde multiple interactions ISO RGD:1348437 6480464 Acetaldehyde results in increased expression of and results in increased activity of MMP9 protein more ... CTD PMID:19110045 acetaldehyde increases expression ISO RGD:1348437 6480464 Acetaldehyde results in increased expression of MMP9 mRNA CTD PMID:19110045 acetic acid multiple interactions EXP 6480464 [Zinc binds to Curcumin] inhibits the reaction [Acetic Acid results in increased expression of MMP9 mRNA] CTD PMID:23933360 acetic acid increases expression EXP 6480464 Acetic Acid results in increased expression of MMP9 mRNA CTD PMID:23933360 acetylcholine affects response to substance ISO RGD:731911 6480464 MMP9 protein affects the susceptibility to Acetylcholine CTD PMID:16979597 acetylsalicylic acid multiple interactions ISO RGD:1348437 6480464 Aspirin inhibits the reaction [HGF results in increased expression of MMP9] CTD PMID:11981761 acetylsalicylic acid multiple interactions EXP 6480464 Aspirin inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of MMP9 protein] CTD PMID:29031619 acetylsalicylic acid decreases secretion ISO RGD:1348437 6480464 Aspirin results in decreased secretion of MMP9 protein CTD PMID:18971601 , PMID:19880272 acetylsalicylic acid decreases secretion ISO RGD:731911 6480464 Aspirin results in decreased secretion of MMP9 protein CTD PMID:19462226 acetylsalicylic acid decreases expression ISO RGD:731911 6480464 Aspirin results in decreased expression of MMP9 mRNA CTD PMID:19462226 acetylsalicylic acid decreases expression ISO RGD:1348437 6480464 Aspirin results in decreased expression of MMP9, Aspirin results in decreased expression of MMP9 mRNA CTD PMID:15928584 more ... acetylsalicylic acid decreases activity ISO RGD:1348437 6480464 Aspirin results in decreased activity of MMP9 protein CTD PMID:20137092 acrolein multiple interactions ISO RGD:1348437 6480464 1 more ... CTD PMID:15531749 more ... acrolein affects secretion ISO RGD:1348437 6480464 Acrolein affects the secretion of MMP9 protein CTD PMID:28947239 acrolein increases expression ISO RGD:1348437 6480464 Acrolein results in increased expression of MMP9 mRNA, Acrolein results in increased expression of MMP9 protein CTD PMID:15531749 , PMID:18006877 acrolein increases activity ISO RGD:1348437 6480464 Acrolein results in increased activity of MMP9 protein CTD PMID:15531749 , PMID:18006877 acrolein multiple interactions ISO RGD:731911 6480464 Acrolein results in increased expression of and results in increased activity of MMP9 protein more ... CTD PMID:17950725 more ... acrolein increases expression ISO RGD:731911 6480464 Acrolein results in increased expression of MMP9 mRNA, Acrolein results in increased expression of MMP9 protein CTD PMID:18006877 acrolein increases activity ISO RGD:731911 6480464 Acrolein results in increased activity of MMP9 protein CTD PMID:17950725 , PMID:18006877 acrolein increases secretion ISO RGD:1348437 6480464 Acrolein results in increased secretion of MMP9 protein CTD PMID:15531749 acrolein increases cleavage ISO RGD:1348437 6480464 Acrolein results in increased cleavage of MMP9 protein CTD PMID:18006877 acrylamide increases expression ISO RGD:731911 6480464 Acrylamide results in increased expression of MMP9 mRNA CTD PMID:30807115 actinomycin D multiple interactions ISO RGD:1348437 6480464 Dactinomycin inhibits the reaction [arsenic trioxide results in increased expression of MMP9 mRNA] CTD PMID:24956101 actinomycin D decreases expression ISO RGD:1348437 6480464 Dactinomycin results in decreased expression of MMP9 mRNA CTD PMID:24956101 aflatoxin B1 decreases methylation ISO RGD:1348437 6480464 Aflatoxin B1 results in decreased methylation of MMP9 gene CTD PMID:27153756 AICA ribonucleotide decreases activity ISO RGD:1348437 6480464 AICA ribonucleotide results in decreased activity of MMP9 protein CTD PMID:20590612 alachlor increases expression EXP 6480464 alachlor results in increased expression of MMP9 mRNA CTD PMID:12419858 aldehydo-D-glucosamine multiple interactions ISO RGD:1348437 6480464 Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] more ... CTD PMID:17498959 , PMID:19375915 aldehydo-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of MMP9 mRNA CTD PMID:17109745 aldehydo-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of MMP9 mRNA], IL1B affects the reaction [Glucosamine results in increased expression of MMP9 mRNA] CTD PMID:17109745 aldehydo-D-glucose multiple interactions EXP 6480464 [Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of MMP9 protein] more ... CTD PMID:22467055 , PMID:31838053 aldehydo-D-glucose increases expression ISO RGD:1348437 6480464 Glucose results in increased expression of MMP9 mRNA CTD PMID:28478229 , PMID:31655124 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of MMP9 protein CTD PMID:31838053 aldehydo-D-glucose multiple interactions ISO RGD:1348437 6480464 [Glucose co-treated with Resveratrol] results in decreased expression of MMP9 mRNA more ... CTD PMID:24064760 more ... aldehydo-D-glucose multiple interactions ISO RGD:731911 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA more ... CTD PMID:24659233 , PMID:24682241 all-trans-retinoic acid multiple interactions ISO RGD:1348437 6480464 Tretinoin results in decreased expression of and results in decreased secretion of MMP9 protein CTD PMID:16914095 all-trans-retinoic acid decreases expression ISO RGD:1348437 6480464 Tretinoin results in decreased expression of MMP9 mRNA CTD PMID:16914095 , PMID:21924320 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of MMP9 mRNA CTD PMID:20488242 all-trans-retinoic acid multiple interactions EXP 6480464 Tretinoin inhibits the reaction [Doxorubicin results in decreased expression of MMP9 mRNA], Tretinoin inhibits the reaction [Doxorubicin results in decreased expression of MMP9 protein] CTD PMID:19357873 all-trans-retinoic acid increases expression ISO RGD:731911 6480464 Tretinoin results in increased expression of MMP9 mRNA CTD PMID:16788091 all-trans-retinyl palmitate multiple interactions EXP 6480464 retinol palmitate promotes the reaction [EP300 protein binds to MMP9 protein], retinol palmitate promotes the reaction [RARA protein binds to MMP9 protein] CTD PMID:17164434 all-trans-retinyl palmitate increases expression EXP 6480464 retinol palmitate results in increased expression of MMP9 mRNA CTD PMID:17164434 allethrin increases expression ISO RGD:1348437 6480464 Allethrins results in increased expression of MMP9 protein CTD PMID:24055895 allopurinol multiple interactions ISO RGD:1348437 6480464 Allopurinol inhibits the reaction [Acrolein results in increased expression of MMP9 protein] CTD PMID:19371603 alloxanthine multiple interactions ISO RGD:1348437 6480464 Oxypurinol inhibits the reaction [Acrolein results in increased expression of MMP9 protein] CTD PMID:19371603 alpha-D-galactose multiple interactions EXP 6480464 fruit extract, Alpinia oxyphylla inhibits the reaction [Galactose results in increased expression of and results in increased activity of MMP9 protein], Galactose results in increased expression of and results in increased activity of MMP9 protein CTD PMID:30367734 alpha-mangostin decreases expression ISO RGD:1348437 6480464 mangostin analog results in decreased expression of MMP9 mRNA, mangostin analog results in decreased expression of MMP9 protein CTD PMID:28722351 alpha-mangostin multiple interactions ISO RGD:1348437 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [mangostin analog results in decreased expression of MMP9 protein], pyrazolanthrone inhibits the reaction [mangostin analog results in decreased expression of MMP9 protein] CTD PMID:28722351 alpha-naphthoflavone multiple interactions EXP 6480464 alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA] CTD PMID:19022365 alpha-naphthoflavone multiple interactions ISO RGD:1348437 6480464 alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased secretion of and results in increased activity of MMP9 protein] CTD PMID:23462309 aluminium atom increases expression EXP 6480464 Aluminum results in increased expression of MMP9 protein CTD PMID:16052892 aluminium oxide increases expression ISO RGD:1348437 6480464 Aluminum Oxide results in increased expression of MMP9 mRNA CTD PMID:16488289 aluminium(0) increases expression EXP 6480464 Aluminum results in increased expression of MMP9 protein CTD PMID:16052892 aminoguanidine multiple interactions EXP 6480464 pimagedine inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA] CTD PMID:18594475 amitrole multiple interactions ISO RGD:1348437 6480464 Amitrole inhibits the reaction [fluvastatin results in decreased expression of MMP9 mRNA] CTD PMID:24964743 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MMP9 mRNA CTD PMID:16483693 Anacardic acid multiple interactions ISO RGD:1348437 6480464 anacardic acid inhibits the reaction [TNF protein results in increased expression of MMP9 protein] CTD PMID:18349320 Anacardic acid multiple interactions ISO RGD:731911 6480464 anacardic acid binds to and results in decreased activity of MMP9 protein CTD PMID:22745359 anagliptin multiple interactions ISO RGD:1348437 6480464 anagliptin inhibits the reaction [Hydrogen Peroxide results in increased expression of MMP9 mRNA] CTD PMID:31586451 anandamide multiple interactions ISO RGD:1348437 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [anandamide results in increased expression of MMP9 mRNA] CTD PMID:16330497 anandamide increases expression ISO RGD:1348437 6480464 anandamide results in increased expression of MMP9 mRNA CTD PMID:16330497 andrographolide multiple interactions ISO RGD:731911 6480464 andrographolide inhibits the reaction [TGFB1 protein results in increased expression of MMP9 mRNA] CTD PMID:31706003 anethole decreases activity ISO RGD:1348437 6480464 anethole results in decreased activity of MMP9 protein CTD PMID:21212515 anethole decreases expression ISO RGD:1348437 6480464 anethole results in decreased expression of MMP9 mRNA CTD PMID:21212515 anthocyanin multiple interactions ISO RGD:731911 6480464 Anthocyanins inhibits the reaction [Carbon Tetrachloride results in decreased expression of MMP9 protein] CTD PMID:30056145 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1348437 6480464 [kahweol acetate co-treated with pyrazolanthrone] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein] more ... CTD PMID:19447859 more ... anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [RELA protein binds to MMP9 promoter] more ... CTD PMID:16213474 , PMID:23774252 anthra[1,9-cd]pyrazol-6(2H)-one decreases activity ISO RGD:1348437 6480464 pyrazolanthrone results in decreased activity of MMP9 protein CTD PMID:22033475 antirheumatic drug decreases expression ISO RGD:1348437 6480464 Antirheumatic Agents results in decreased expression of MMP9 mRNA CTD PMID:17696278 antirheumatic drug multiple interactions ISO RGD:1348437 6480464 [Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of MMP9 mRNA, [Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of MMP9 protein CTD PMID:23146660 antroquinonol multiple interactions ISO RGD:1348437 6480464 antroquinonol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA], antroquinonol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] CTD PMID:25656647 apigenin multiple interactions ISO RGD:1348437 6480464 Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein], Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] CTD PMID:22634262 apocynin multiple interactions EXP 6480464 acetovanillone inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA] more ... CTD PMID:23270704 , PMID:23774252 apocynin multiple interactions ISO RGD:1348437 6480464 acetovanillone inhibits the reaction [Hydrogen Peroxide results in increased expression of MMP9 mRNA] CTD PMID:26514923 arachidonic acid increases secretion ISO RGD:1348437 6480464 Arachidonic Acid results in increased secretion of MMP9 protein CTD PMID:16185265 arachidonic acid increases expression ISO RGD:1348437 6480464 Arachidonic Acid results in increased expression of MMP9 mRNA CTD PMID:16185265 arachidonic acid multiple interactions ISO RGD:1348437 6480464 Isotretinoin inhibits the reaction [Arachidonic Acid results in increased expression of MMP9 mRNA], Isotretinoin inhibits the reaction [Arachidonic Acid results in increased secretion of MMP9 protein] CTD PMID:16185265 arsane increases expression ISO RGD:731911 6480464 Arsenic results in increased expression of MMP9 mRNA CTD PMID:19654921 arsane increases expression ISO RGD:1348437 6480464 Arsenic results in increased expression of MMP9 protein CTD PMID:26721309 arsane increases secretion ISO RGD:1348437 6480464 Arsenic results in increased secretion of MMP9 protein CTD PMID:25273566 arsane multiple interactions ISO RGD:1348437 6480464 [Arsenic results in increased expression of and results in increased secretion of MMP9 protein] which results in decreased abundance of Cholesterol, HDL more ... CTD PMID:18539681 more ... arsenic atom increases expression ISO RGD:731911 6480464 Arsenic results in increased expression of MMP9 mRNA CTD PMID:19654921 arsenic atom increases expression ISO RGD:1348437 6480464 Arsenic results in increased expression of MMP9 protein CTD PMID:26721309 arsenic atom increases secretion ISO RGD:1348437 6480464 Arsenic results in increased secretion of MMP9 protein CTD PMID:25273566 arsenic atom multiple interactions ISO RGD:1348437 6480464 [Arsenic results in increased expression of and results in increased secretion of MMP9 protein] which results in decreased abundance of Cholesterol, HDL more ... CTD PMID:18539681 more ... arsenite(3-) increases expression ISO RGD:1348437 6480464 arsenite results in increased expression of MMP9 protein CTD PMID:12488483 arsenite(3-) increases methylation ISO RGD:1348437 6480464 arsenite results in increased methylation of MMP9 promoter CTD PMID:23974009 arsenite(3-) increases expression ISO RGD:731911 6480464 arsenite results in increased expression of MMP9 mRNA CTD PMID:18296743 arsenite(3-) increases secretion ISO RGD:1348437 6480464 arsenite results in increased secretion of MMP9 protein CTD PMID:22011395 arsenite(3-) decreases expression ISO RGD:731911 6480464 arsenite results in decreased expression of MMP9 mRNA CTD PMID:18929588 arsenite(3-) multiple interactions ISO RGD:731911 6480464 Dietary Fats promotes the reaction [arsenite results in increased expression of MMP9 mRNA], TRP53 protein affects the reaction [arsenite results in decreased expression of MMP9 mRNA] CTD PMID:18296743 , PMID:18929588 arsenite(3-) affects expression ISO RGD:731911 6480464 arsenite affects the expression of MMP9 mRNA CTD PMID:15738583 arsenous acid decreases expression ISO RGD:731911 6480464 Arsenic Trioxide results in decreased expression of MMP9 mRNA, Arsenic Trioxide results in decreased expression of MMP9 protein CTD PMID:23210436 arsenous acid decreases activity ISO RGD:1348437 6480464 Arsenic Trioxide results in decreased activity of MMP9 protein CTD PMID:21969006 more ... arsenous acid multiple interactions ISO RGD:1348437 6480464 [acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased activity of MMP9 protein more ... CTD PMID:15962302 more ... arsenous acid decreases response to substance ISO RGD:1348437 6480464 MMP9 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:24956101 arsenous acid decreases expression ISO RGD:1348437 6480464 Arsenic Trioxide results in decreased expression of MMP9 mRNA, Arsenic Trioxide results in decreased expression of MMP9 protein CTD PMID:15962302 more ... arsenous acid increases expression ISO RGD:1348437 6480464 Arsenic Trioxide results in increased expression of MMP9 more ... CTD PMID:15949266 more ... artesunate multiple interactions EXP 6480464 artesunate inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of MMP9 protein] CTD PMID:29031619 artesunate decreases expression ISO RGD:1348437 6480464 Artesunate results in decreased expression of MMP9 mRNA CTD PMID:30551460 artesunate multiple interactions ISO RGD:1348437 6480464 Chloroquine inhibits the reaction [Artesunate results in decreased expression of MMP9 mRNA] CTD PMID:30551460 atorvastatin calcium multiple interactions ISO RGD:1348437 6480464 Atorvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] CTD PMID:15728660 atorvastatin calcium increases activity EXP 6480464 Atorvastatin results in increased activity of MMP9 protein CTD PMID:23831763 ATP multiple interactions EXP 6480464 1 more ... CTD PMID:20195827 ATP increases activity ISO RGD:731911 6480464 Adenosine Triphosphate results in increased activity of MMP9 protein CTD PMID:26522449 ATP multiple interactions ISO RGD:731911 6480464 azetidine analog inhibits the reaction [Adenosine Triphosphate results in increased expression of MMP9 protein] CTD PMID:26522449 ATP increases secretion EXP 6480464 Adenosine Triphosphate results in increased secretion of MMP9 protein CTD PMID:20195827 ATP increases activity EXP 6480464 Adenosine Triphosphate results in increased activity of MMP9 protein CTD PMID:20195827 azetidine multiple interactions ISO RGD:731911 6480464 azetidine analog inhibits the reaction [Adenosine Triphosphate results in increased expression of MMP9 protein] CTD PMID:26522449 baicalein multiple interactions ISO RGD:1348437 6480464 baicalein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] CTD PMID:19804834 baicalein multiple interactions ISO RGD:731911 6480464 baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA] CTD PMID:22369883 baicalein decreases activity ISO RGD:1348437 6480464 baicalein results in decreased activity of MMP9 protein CTD PMID:21803068 BAPTA multiple interactions ISO RGD:1348437 6480464 1 more ... CTD PMID:19371603 beclomethasone decreases expression ISO RGD:1348437 6480464 Beclomethasone results in decreased expression of MMP9 protein CTD PMID:10452757 beclomethasone multiple interactions ISO RGD:1348437 6480464 Beclomethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] CTD PMID:10455257 benazepril increases activity ISO RGD:731911 6480464 benazepril results in increased activity of MMP9 protein CTD PMID:15339989 benazepril decreases expression ISO RGD:1348437 6480464 benazepril results in decreased expression of MMP9 protein CTD PMID:20981132 benazepril multiple interactions EXP 6480464 benazepril inhibits the reaction [Doxorubicin results in decreased expression of MMP9 mRNA], benazepril inhibits the reaction [Doxorubicin results in decreased expression of MMP9 protein] CTD PMID:19357873 benomyl decreases expression EXP 6480464 Benomyl results in decreased expression of MMP9 protein CTD PMID:10026946 benomyl decreases expression ISO RGD:1348437 6480464 Benomyl results in decreased expression of MMP9 mRNA CTD PMID:25530041 benzalkonium chloride multiple interactions ISO RGD:731911 6480464 [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MMP9 mRNA CTD PMID:30171875 benzamide multiple interactions ISO RGD:731911 6480464 benzamide analog inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of MMP9 mRNA] CTD PMID:29935282 benzene increases expression ISO RGD:1348437 6480464 Benzene results in increased expression of MMP9 mRNA CTD PMID:19162166 benzene affects expression ISO RGD:1348437 6480464 Benzene affects the expression of MMP9 mRNA CTD PMID:31154059 benzo[a]pyrene decreases expression ISO RGD:1348437 6480464 Benzo(a)pyrene results in decreased expression of MMP9 mRNA CTD PMID:20106945 , PMID:30659931 benzo[a]pyrene multiple interactions ISO RGD:1348437 6480464 LINC00673 affects the reaction [Benzo(a)pyrene results in increased expression of MMP9 protein], U 0126 inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA] CTD PMID:25724548 , PMID:31778776 benzo[a]pyrene increases expression ISO RGD:1348437 6480464 Benzo(a)pyrene results in increased expression of MMP9 mRNA, Benzo(a)pyrene results in increased expression of MMP9 protein CTD PMID:15922868 more ... benzo[a]pyrene affects expression ISO RGD:1348437 6480464 Benzo(a)pyrene affects the expression of MMP9 mRNA CTD PMID:31154059 benzo[a]pyrene multiple interactions ISO RGD:731911 6480464 baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA] CTD PMID:22369883 benzo[a]pyrene increases expression ISO RGD:731911 6480464 Benzo(a)pyrene results in increased expression of MMP9 mRNA CTD PMID:22369883 benzo[a]pyrene affects expression ISO RGD:731911 6480464 Benzo(a)pyrene affects the expression of MMP9 mRNA CTD PMID:22342234 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of MMP9 mRNA, Benzo(a)pyrene results in increased expression of MMP9 protein CTD PMID:19022365 , PMID:21467743 benzo[a]pyrene increases activity ISO RGD:1348437 6480464 Benzo(a)pyrene results in increased activity of MMP9 protein CTD PMID:15922868 benzo[a]pyrene multiple interactions EXP 6480464 alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA] CTD PMID:19022365 benzo[a]pyrene decreases expression ISO RGD:731911 6480464 Benzo(a)pyrene results in decreased expression of MMP9 mRNA CTD PMID:20713471 benzofurans multiple interactions ISO RGD:1348437 6480464 Benzofurans analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] CTD PMID:30696844 benzyl acetate increases expression ISO RGD:1348437 6480464 benzyl acetate results in increased expression of MMP9 mRNA, benzyl acetate results in increased expression of MMP9 protein CTD PMID:22952646 Bergenin multiple interactions ISO RGD:731911 6480464 [TNFSF11 protein co-treated with Pyruvaldehyde co-treated with bergenin] results in decreased expression of MMP9 mRNA CTD PMID:31369791 beta-D-glucosamine multiple interactions ISO RGD:1348437 6480464 Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] more ... CTD PMID:17498959 , PMID:19375915 beta-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of MMP9 mRNA CTD PMID:17109745 beta-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of MMP9 mRNA], IL1B affects the reaction [Glucosamine results in increased expression of MMP9 mRNA] CTD PMID:17109745 beta-hexachlorocyclohexane increases expression ISO RGD:1348437 6480464 beta-hexachlorocyclohexane results in increased expression of MMP9 protein CTD PMID:12948864 beta-naphthoflavone increases expression ISO RGD:1348437 6480464 beta-Naphthoflavone results in increased expression of MMP9 mRNA CTD PMID:32151702 betulinic acid multiple interactions ISO RGD:731911 6480464 betulinic acid inhibits the reaction [TNFSF11 protein results in increased secretion of MMP9 protein] CTD PMID:24463094 biochanin A decreases activity ISO RGD:1348437 6480464 biochanin A results in decreased activity of MMP9 protein CTD PMID:16598420 biphenyl-2-ol affects binding ISO RGD:1348437 6480464 2-phenylphenol binds to MMP9 protein CTD PMID:32278787 bis(2-chloroethyl) sulfide increases expression ISO RGD:1348437 6480464 Mustard Gas results in increased expression of MMP9 mRNA CTD PMID:18809459 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:1348437 6480464 Mustard Gas inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA], Mustard Gas inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein] CTD PMID:26082309 bis(2-chloroethyl) sulfide increases expression ISO RGD:731911 6480464 Mustard Gas results in increased expression of MMP9 mRNA, Mustard Gas results in increased expression of MMP9 protein CTD PMID:16489579 more ... bis(2-chloroethyl) sulfide increases expression EXP 6480464 Mustard Gas results in increased expression of MMP9 protein CTD PMID:20659490 bis(2-chloroethyl) sulfide increases secretion ISO RGD:1348437 6480464 Mustard Gas results in increased secretion of MMP9 protein CTD PMID:18809459 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of MMP9 mRNA CTD PMID:20920545 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:731911 6480464 Diethylhexyl Phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of MMP9 mRNA] CTD PMID:29718165 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1348437 6480464 Diethylhexyl Phthalate results in increased expression of MMP9 mRNA, Diethylhexyl Phthalate results in increased expression of MMP9 protein CTD PMID:19956873 , PMID:30944277 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1348437 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Diethylhexyl Phthalate results in increased expression of MMP9 mRNA] more ... CTD PMID:19956873 bisdemethoxycurcumin multiple interactions ISO RGD:1348437 6480464 bis(4-hydroxycinnamoyl)methane results in decreased secretion of and results in decreased activity of MMP9 protein CTD PMID:18495463 bisphenol A decreases expression ISO RGD:1348437 6480464 bisphenol A results in decreased expression of MMP9 mRNA CTD PMID:31230753 bisphenol A decreases expression ISO RGD:731911 6480464 bisphenol A results in decreased expression of MMP9 mRNA CTD PMID:30303745 , PMID:30675821 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MMP9 mRNA CTD PMID:27925325 more ... bisphenol A multiple interactions ISO RGD:731911 6480464 [bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of MMP9 mRNA more ... CTD PMID:28903498 , PMID:29718165 bisphenol A increases secretion ISO RGD:1348437 6480464 bisphenol A results in increased secretion of MMP9 protein CTD PMID:18585891 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MMP9 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1348437 6480464 bisphenol A results in increased expression of MMP9 mRNA, bisphenol A results in increased expression of MMP9 protein CTD PMID:19956873 more ... bisphenol A multiple interactions ISO RGD:1348437 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of MMP9 protein] more ... CTD PMID:19956873 more ... Bisphenol A diglycidyl ether multiple interactions EXP 6480464 2, 2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein]] CTD PMID:27274199 bisphenol F increases expression ISO RGD:731911 6480464 bisphenol F results in increased expression of MMP9 mRNA CTD PMID:30951980 bitertanol affects binding ISO RGD:1348437 6480464 bitertanol binds to MMP9 protein CTD PMID:32278787 bleomycin A2 multiple interactions EXP 6480464 allyl sulfide inhibits the reaction [Bleomycin results in increased expression of MMP9 protein], tripterine inhibits the reaction [Bleomycin results in increased expression of MMP9 protein] CTD PMID:23656969 , PMID:26768587 bleomycin A2 multiple interactions ISO RGD:731911 6480464 12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [Bleomycin results in increased expression of MMP9 mRNA] more ... CTD PMID:26526764 more ... bleomycin A2 increases expression ISO RGD:731911 6480464 Bleomycin results in increased expression of MMP9 mRNA, Bleomycin results in increased expression of MMP9 protein CTD PMID:26526764 more ... bleomycin A2 increases expression EXP 6480464 Bleomycin results in increased expression of MMP9 protein CTD PMID:23656969 , PMID:26768587 bortezomib multiple interactions ISO RGD:1348437 6480464 Bortezomib promotes the reaction [butein results in decreased expression of MMP9 protein] CTD PMID:20696233 BQ 123 multiple interactions ISO RGD:1348437 6480464 [BQ 788 co-treated with cyclo(Trp-Asp-Pro-Val-Leu)] inhibits the reaction [EDN1 protein results in increased secretion of and results in increased activity of MMP9 protein], cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [EDN1 protein results in increased secretion of and results in increased activity of MMP9 protein] CTD PMID:12875994 BQ 123 multiple interactions ISO RGD:731911 6480464 cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [[APOE protein affects the susceptibility to Vehicle Emissions] which results in increased expression of MMP9 mRNA], cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [[APOE protein affects the susceptibility to Vehicle Emissions] which results in increased expression of MMP9 protein] CTD PMID:19150882 budesonide multiple interactions EXP 6480464 Budesonide inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein] more ... CTD PMID:15734790 , PMID:25313925 bufalin decreases activity ISO RGD:1348437 6480464 bufalin results in decreased activity of MMP9 protein CTD PMID:21922632 bufalin decreases secretion ISO RGD:1348437 6480464 bufalin results in decreased secretion of MMP9 protein CTD PMID:23949904 bufalin multiple interactions ISO RGD:1348437 6480464 bufalin results in decreased expression of and results in decreased activity of MMP9 protein CTD PMID:23949904 bufalin decreases expression ISO RGD:1348437 6480464 bufalin results in decreased expression of MMP9 mRNA CTD PMID:23949904 buta-1,3-diene decreases expression ISO RGD:731911 6480464 1, 3-butadiene results in decreased expression of MMP9 mRNA CTD PMID:29038090 butanal increases expression ISO RGD:1348437 6480464 butyraldehyde results in increased expression of MMP9 mRNA CTD PMID:26079696 butane-2,3-dione increases secretion ISO RGD:1348437 6480464 Diacetyl results in increased secretion of MMP9 protein CTD PMID:31381966 butane-2,3-dione increases expression ISO RGD:1348437 6480464 Diacetyl results in increased expression of MMP9 mRNA CTD PMID:31381966 butein decreases expression ISO RGD:1348437 6480464 butein results in decreased expression of MMP9 mRNA, butein results in decreased expression of MMP9 protein CTD PMID:20696233 butein multiple interactions ISO RGD:1348437 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [butein results in decreased expression of MMP9 protein] more ... CTD PMID:20696233 Butylbenzyl phthalate increases expression ISO RGD:1348437 6480464 butylbenzyl phthalate results in increased expression of MMP9 protein CTD PMID:31212022 cadmium atom increases secretion ISO RGD:1348437 6480464 Cadmium results in increased secretion of MMP9 mRNA, Cadmium results in increased secretion of MMP9 protein CTD PMID:20049202 , PMID:22626610 cadmium atom multiple interactions ISO RGD:731911 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MMP9 protein CTD PMID:31793751 cadmium atom affects expression ISO RGD:1348437 6480464 Cadmium affects the expression of MMP9 mRNA CTD PMID:31154059 cadmium atom multiple interactions ISO RGD:1348437 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Cadmium results in increased expression of MMP9 mRNA] more ... CTD PMID:26514923 , PMID:31468104 cadmium atom increases expression ISO RGD:1348437 6480464 Cadmium results in increased expression of MMP9 mRNA, Cadmium results in increased expression of MMP9 protein CTD PMID:22884995 , PMID:26514923 cadmium atom multiple interactions EXP 6480464 Ipratropium promotes the reaction [Formoterol Fumarate inhibits the reaction [Cadmium results in increased activity of MMP9 protein]] CTD PMID:20826145 cadmium dichloride increases expression ISO RGD:731911 6480464 Cadmium Chloride results in increased expression of MMP9 protein CTD PMID:25502771 , PMID:28830677 cadmium dichloride increases expression ISO RGD:1348437 6480464 Cadmium Chloride results in increased expression of MMP9 protein CTD PMID:28830677 , PMID:29179951 cadmium dichloride multiple interactions ISO RGD:1348437 6480464 4-(6-bromo-1 more ... CTD PMID:28830677 more ... cadmium dichloride increases secretion ISO RGD:1348437 6480464 Cadmium Chloride results in increased secretion of MMP9 protein CTD PMID:27510461 , PMID:28527916 cadmium dichloride decreases expression ISO RGD:1348437 6480464 Cadmium Chloride results in decreased expression of MMP9 mRNA CTD PMID:26238599 cadmium dichloride increases activity EXP 6480464 Cadmium Chloride results in increased activity of MMP9 protein CTD PMID:20826145 , PMID:25313925 cadmium dichloride multiple interactions EXP 6480464 Budesonide inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein] more ... CTD PMID:20826145 , PMID:25313925 cadmium dichloride multiple interactions ISO RGD:731911 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MMP9 protein, tetrahydrocurcumin inhibits the reaction [Cadmium Chloride results in increased expression of MMP9 protein] CTD PMID:25502771 , PMID:31793751 calcitriol decreases expression ISO RGD:1348437 6480464 Calcitriol results in decreased expression of MMP9 mRNA CTD PMID:26485663 calcium dichloride increases expression EXP 6480464 Calcium Chloride results in increased expression of MMP9 mRNA, Calcium Chloride results in increased expression of MMP9 protein CTD PMID:20621845 calcium dichloride increases expression ISO RGD:731911 6480464 Calcium Chloride results in increased expression of MMP9 mRNA, Calcium Chloride results in increased expression of MMP9 protein CTD PMID:22728078 calcium dichloride multiple interactions ISO RGD:731911 6480464 Quercetin inhibits the reaction [Calcium Chloride results in increased activity of MMP9 protein] more ... CTD PMID:21530968 more ... calcium dichloride increases activity ISO RGD:731911 6480464 Calcium Chloride results in increased activity of MMP9 protein CTD PMID:21530968 , PMID:24337353 camptothecin decreases response to substance ISO RGD:1348437 6480464 MMP9 mRNA results in decreased susceptibility to Camptothecin CTD PMID:25269479 camptothecin decreases methylation ISO RGD:1348437 6480464 Camptothecin results in decreased methylation of MMP9 gene CTD PMID:30720231 candesartan decreases expression EXP 6480464 candesartan results in decreased expression of MMP9 mRNA, candesartan results in decreased expression of MMP9 protein CTD PMID:19047581 cantharidin decreases expression ISO RGD:1348437 6480464 Cantharidin results in decreased expression of MMP9 protein CTD PMID:31945315 capsaicin multiple interactions ISO RGD:1348437 6480464 4-aminobenzamide inhibits the reaction [Capsaicin results in increased activity of MMP9 protein] more ... CTD PMID:21310942 , PMID:21462327 capsaicin increases expression ISO RGD:1348437 6480464 Capsaicin results in increased expression of MMP9 mRNA CTD PMID:21310942 , PMID:22230393 carbamazepine affects expression ISO RGD:1348437 6480464 Carbamazepine affects the expression of MMP9 mRNA CTD PMID:25979313 carbendazim decreases expression ISO RGD:1348437 6480464 carbendazim results in decreased expression of MMP9 mRNA CTD PMID:25530041 carbon atom increases expression ISO RGD:1348437 6480464 Carbon results in increased expression of MMP9 mRNA CTD PMID:26880698 carbon atom multiple interactions ISO RGD:1348437 6480464 Carbon promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of MMP9 mRNA], lipopolysaccharide, E coli O55-B5 promotes the reaction [Carbon results in increased expression of MMP9 mRNA] CTD PMID:26880698 carbon monoxide increases expression ISO RGD:731911 6480464 Carbon Monoxide results in increased expression of MMP9 mRNA CTD PMID:20197249 carbon nanotube increases expression ISO RGD:1348437 6480464 Nanotubes, Carbon results in increased expression of MMP9 mRNA CTD PMID:15585362 , PMID:25511174 carbon nanotube increases expression ISO RGD:731911 6480464 Nanotubes, Carbon analog results in increased expression of MMP9 mRNA, Nanotubes, Carbon results in increased expression of MMP9 mRNA CTD PMID:25554681 , PMID:30081225 carbon nanotube affects expression ISO RGD:731911 6480464 Nanotubes, Carbon affects the expression of MMP9 mRNA, Nanotubes, Carbon analog affects the expression of MMP9 mRNA CTD PMID:23845593 , PMID:25554681 carvedilol affects activity ISO RGD:1348437 6480464 carvedilol affects the activity of MMP9 protein CTD PMID:16574429 carvedilol decreases activity EXP 6480464 carvedilol results in decreased activity of MMP9 protein CTD PMID:16310260 carvedilol multiple interactions ISO RGD:1348437 6480464 carvedilol inhibits the reaction [TNF protein results in increased expression of MMP9 protein] CTD PMID:17964422 carvedilol decreases expression EXP 6480464 carvedilol results in decreased expression of MMP9 mRNA CTD PMID:18971572 carvedilol multiple interactions EXP 6480464 carvedilol inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA] CTD PMID:16213474 casticin decreases expression ISO RGD:731911 6480464 casticin results in decreased expression of MMP9 protein CTD PMID:28444820 celastrol multiple interactions EXP 6480464 tripterine inhibits the reaction [Bleomycin results in increased expression of MMP9 protein] CTD PMID:26768587 celecoxib multiple interactions ISO RGD:731911 6480464 Celecoxib inhibits the reaction [Dihematoporphyrin Ether results in increased expression of MMP9 protein] CTD PMID:16230411 celecoxib multiple interactions EXP 6480464 Celecoxib promotes the reaction [Carbon Tetrachloride results in increased expression of MMP9 mRNA] CTD PMID:16420518 ceric oxide increases activity ISO RGD:1348437 6480464 ceric oxide results in increased activity of MMP9 protein CTD PMID:23726862 ceric oxide increases secretion ISO RGD:1348437 6480464 ceric oxide results in increased secretion of MMP9 protein CTD PMID:23726862 CGS-21680 decreases activity ISO RGD:1348437 6480464 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine results in decreased activity of MMP9 protein CTD PMID:16783407 CGS-21680 decreases expression ISO RGD:1348437 6480464 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine results in decreased expression of MMP9 mRNA CTD PMID:16783407 chalcones decreases expression ISO RGD:1348437 6480464 Chalcones results in decreased expression of MMP9 mRNA CTD PMID:23562496 chalcones multiple interactions ISO RGD:1348437 6480464 Chalcones results in decreased expression of and results in decreased activity of MMP9 protein CTD PMID:23562496 chelerythrine multiple interactions ISO RGD:1348437 6480464 [AG 1879 co-treated with chelerythrine] inhibits the reaction [CXCL8 protein results in increased secretion of MMP9 protein] CTD PMID:15831558 chitin multiple interactions ISO RGD:1348437 6480464 [[Aptamers, Nucleotide binds to Chitin] which binds to MUC1 protein] promotes the reaction [[Docetaxel binds to Chitin] which results in decreased expression of MMP9 mRNA] more ... CTD PMID:30041514 chloroprene decreases expression ISO RGD:731911 6480464 Chloroprene results in decreased expression of MMP9 mRNA CTD PMID:23125180 chloroquine multiple interactions ISO RGD:1348437 6480464 Chloroquine inhibits the reaction [Artesunate results in decreased expression of MMP9 mRNA] more ... CTD PMID:24145604 more ... chloroquine increases expression ISO RGD:1348437 6480464 Chloroquine results in increased expression of MMP9 mRNA CTD PMID:30551460 chloroquine decreases expression ISO RGD:1348437 6480464 Chloroquine results in decreased expression of MMP9 mRNA, Chloroquine results in decreased expression of MMP9 protein CTD PMID:24273604 chlorpromazine multiple interactions ISO RGD:1348437 6480464 Chlorpromazine inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA], Chlorpromazine inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein] CTD PMID:25200491 choline multiple interactions ISO RGD:731911 6480464 3 more ... CTD PMID:22915297 more ... chromium(6+) affects expression ISO RGD:731911 6480464 chromium hexavalent ion affects the expression of MMP9 mRNA CTD PMID:28472532 chromium(6+) increases expression ISO RGD:1348437 6480464 chromium hexavalent ion results in increased expression of MMP9 protein CTD PMID:23518002 , PMID:25448439 chromium(6+) multiple interactions ISO RGD:1348437 6480464 Luteolin inhibits the reaction [chromium hexavalent ion results in increased expression of MMP9 protein] CTD PMID:25448439 chrysin multiple interactions ISO RGD:1348437 6480464 chrysin inhibits the reaction [nickel chloride results in increased expression of and results in increased activity of MMP9 protein] CTD PMID:30016632 cinnamic acid multiple interactions ISO RGD:731911 6480464 cinnamic acid analog binds to and results in decreased activity of MMP9 protein CTD PMID:30048736 Cinnamyl anthranilate increases expression ISO RGD:1348437 6480464 cinnamyl anthranilate results in increased expression of MMP9 mRNA, cinnamyl anthranilate results in increased expression of MMP9 protein CTD PMID:22952646 cisplatin decreases expression ISO RGD:1348437 6480464 Cisplatin results in decreased expression of MMP9, Cisplatin results in decreased expression of MMP9 protein CTD PMID:21789004 , PMID:30396169 cisplatin decreases expression ISO RGD:731911 6480464 Cisplatin results in decreased expression of MMP9 mRNA CTD PMID:29148169 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of MMP9 mRNA CTD PMID:22023808 cisplatin increases activity ISO RGD:1348437 6480464 Cisplatin results in increased activity of MMP9 protein CTD PMID:21618587 cisplatin multiple interactions ISO RGD:1348437 6480464 [[BSG binds to PPIA] which results in decreased susceptibility to Cisplatin] which results in increased expression of MMP9 more ... CTD PMID:20705681 more ... clarithromycin decreases expression EXP 6480464 Clarithromycin results in decreased expression of MMP9 mRNA CTD PMID:9869567 clofibrate decreases secretion ISO RGD:1348437 6480464 Clofibrate results in decreased secretion of MMP9 protein CTD PMID:16860414 clopidogrel decreases activity EXP 6480464 clopidogrel results in decreased activity of MMP9 protein CTD PMID:20195827 cobalt atom multiple interactions ISO RGD:1348437 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of MMP9 mRNA CTD PMID:18078969 cobalt atom multiple interactions ISO RGD:731911 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA, TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA] CTD PMID:23503329 cocaine multiple interactions ISO RGD:1348437 6480464 Cocaine results in decreased expression of and results in decreased activity of MMP9 protein CTD PMID:18000554 cocaine increases expression EXP 6480464 Cocaine results in increased expression of MMP9 mRNA CTD PMID:27899881 coenzyme Q10 multiple interactions EXP 6480464 coenzyme Q10 inhibits the reaction [Doxorubicin results in increased expression of MMP9 protein] CTD PMID:27087047 cortisol multiple interactions ISO RGD:1348437 6480464 Hydrocortisone inhibits the reaction [IL1A protein results in increased activity of MMP9 protein] more ... CTD PMID:18722610 crocetin multiple interactions EXP 6480464 crocetin inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA] CTD PMID:16864425 crocidolite asbestos increases expression ISO RGD:731911 6480464 Asbestos, Crocidolite results in increased expression of MMP9 protein CTD PMID:16574944 crocidolite asbestos increases expression ISO RGD:1348437 6480464 Asbestos, Crocidolite results in increased expression of MMP9 protein CTD PMID:16966607 crotonaldehyde increases secretion ISO RGD:1348437 6480464 2-butenal results in increased secretion of MMP9 protein CTD PMID:28947239 crotonaldehyde increases expression ISO RGD:1348437 6480464 2-butenal results in increased expression of MMP9 mRNA CTD PMID:28947239 curcumin multiple interactions ISO RGD:1348437 6480464 3-caffeoyl-4-dihydrocaffeoylquinic acid promotes the reaction [Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]] more ... CTD PMID:16219905 more ... curcumin decreases activity ISO RGD:1348437 6480464 Curcumin results in decreased activity of MMP9 protein CTD PMID:17996675 , PMID:22771723 curcumin decreases expression ISO RGD:1348437 6480464 Curcumin results in decreased expression of MMP9 protein CTD PMID:17996675 , PMID:18226269 curcumin decreases expression ISO RGD:731911 6480464 Curcumin results in decreased expression of MMP9 protein CTD PMID:17440100 , PMID:18829502 curcumin increases activity EXP 6480464 Curcumin results in increased activity of MMP9 protein CTD PMID:17531121 curcumin affects expression EXP 6480464 Curcumin affects the expression of MMP9 mRNA, Curcumin affects the expression of MMP9 protein CTD PMID:18379247 curcumin multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in increased activity of MMP9 protein] more ... CTD PMID:17531121 more ... curcumin multiple interactions ISO RGD:731911 6480464 [Curcumin co-treated with gemcitabine] results in decreased expression of MMP9 protein CTD PMID:17440100 cycloprothrin affects binding ISO RGD:1348437 6480464 cycloprothrin binds to MMP9 protein CTD PMID:32278787 cyclosporin A decreases expression ISO RGD:1348437 6480464 Cyclosporine results in decreased expression of MMP9 mRNA CTD PMID:27989131 cyhalothrin affects binding ISO RGD:1348437 6480464 cyhalothrin binds to MMP9 protein CTD PMID:32278787 cypermethrin multiple interactions ISO RGD:731911 6480464 cypermethrin promotes the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] CTD PMID:29471534 cysteamine decreases activity ISO RGD:1348437 6480464 Cysteamine results in decreased activity of MMP9 protein CTD PMID:22532830 cysteamine multiple interactions ISO RGD:1348437 6480464 Cysteamine results in increased expression of and results in decreased activity of MMP9 protein CTD PMID:22532830 cysteamine increases expression ISO RGD:1348437 6480464 Cysteamine results in increased expression of MMP9 mRNA CTD PMID:22532830 cytochalasin D multiple interactions ISO RGD:1348437 6480464 Cytochalasin D promotes the reaction [TNF results in increased expression of MMP9 mRNA] CTD PMID:17560598 D-glucose multiple interactions EXP 6480464 [Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of MMP9 protein] more ... CTD PMID:22467055 , PMID:31838053 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of MMP9 protein CTD PMID:31838053 D-glucose multiple interactions ISO RGD:1348437 6480464 [Glucose co-treated with Resveratrol] results in decreased expression of MMP9 mRNA more ... CTD PMID:24064760 more ... D-glucose increases expression ISO RGD:1348437 6480464 Glucose results in increased expression of MMP9 mRNA CTD PMID:28478229 , PMID:31655124 D-glucose multiple interactions ISO RGD:731911 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA more ... CTD PMID:24659233 , PMID:24682241 daidzein multiple interactions EXP 6480464 daidzein inhibits the reaction [Flutamide results in increased expression of MMP9 mRNA] CTD PMID:23135684 dapsone multiple interactions ISO RGD:731911 6480464 Dapsone inhibits the reaction [Paraquat results in increased expression of MMP9 protein] CTD PMID:21765237 Deguelin decreases activity ISO RGD:1348437 6480464 deguelin results in decreased activity of MMP9 protein CTD PMID:25322282 Deguelin decreases expression ISO RGD:1348437 6480464 deguelin results in decreased expression of MMP9 mRNA, deguelin results in decreased expression of MMP9 protein CTD PMID:26884827 Deguelin multiple interactions ISO RGD:1348437 6480464 deguelin inhibits the reaction [TNF protein results in increased expression of MMP9 protein] CTD PMID:17015749 delphinidin multiple interactions ISO RGD:731911 6480464 delphinidin promotes the reaction [Carbon Tetrachloride results in increased expression of MMP9 protein] CTD PMID:20371262 demethoxycurcumin multiple interactions ISO RGD:1348437 6480464 demethoxycurcumin results in decreased secretion of and results in decreased activity of MMP9 protein CTD PMID:18495463 Deoxyschizandrin decreases expression ISO RGD:1348437 6480464 schizandrin A results in decreased expression of MMP9 protein CTD PMID:32057180 desferrioxamine B decreases expression ISO RGD:731911 6480464 Deferoxamine results in decreased expression of MMP9 mRNA CTD PMID:31238089 desferrioxamine B multiple interactions ISO RGD:731911 6480464 Deferoxamine inhibits the reaction [TF protein results in increased expression of MMP9 mRNA], TF protein affects the reaction [Deferoxamine results in increased expression of MMP9 mRNA] CTD PMID:31238089 dexamethasone multiple interactions ISO RGD:731911 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA more ... CTD PMID:14515793 more ... dexamethasone decreases expression ISO RGD:1348437 6480464 Dexamethasone results in decreased expression of MMP9 mRNA CTD PMID:25047013 dexamethasone decreases expression ISO RGD:731911 6480464 Dexamethasone results in decreased expression of MMP9 mRNA, Dexamethasone results in decreased expression of MMP9 protein CTD PMID:23210436 dexamethasone increases expression ISO RGD:731911 6480464 Dexamethasone results in increased expression of MMP9 mRNA CTD PMID:21041162 dexamethasone multiple interactions ISO RGD:1348437 6480464 Dexamethasone inhibits the reaction [sodium bisulfide results in increased expression of MMP9 mRNA] more ... CTD PMID:10455257 more ... dexamethasone affects expression EXP 6480464 Dexamethasone affects the expression of MMP9 mRNA, Dexamethasone affects the expression of MMP9 protein CTD PMID:18379247 dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [Hydrogen Sulfide results in increased expression of MMP9 mRNA] more ... CTD PMID:15963473 more ... dextran sulfate multiple interactions ISO RGD:731911 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MMP9 mRNA more ... CTD PMID:19285099 more ... dextran sulfate increases expression ISO RGD:731911 6480464 Dextran Sulfate results in increased expression of MMP9 mRNA, Dextran Sulfate results in increased expression of MMP9 protein CTD PMID:19285099 , PMID:27125760 diallyl disulfide multiple interactions ISO RGD:1348437 6480464 diallyl disulfide results in decreased expression of and results in decreased activity of MMP9 protein CTD PMID:20600798 diallyl disulfide affects expression ISO RGD:1348437 6480464 diallyl disulfide affects the expression of MMP9 protein CTD PMID:21695758 diallyl disulfide decreases expression ISO RGD:1348437 6480464 diallyl disulfide results in decreased expression of MMP9 mRNA CTD PMID:20600798 Diallyl sulfide affects expression ISO RGD:1348437 6480464 allyl sulfide affects the expression of MMP9 protein CTD PMID:21695758 Diallyl sulfide multiple interactions EXP 6480464 allyl sulfide inhibits the reaction [Bleomycin results in increased expression of MMP9 protein] CTD PMID:23656969 diallyl trisulfide affects expression ISO RGD:1348437 6480464 diallyl trisulfide affects the expression of MMP9 protein CTD PMID:21695758 diallyl trisulfide decreases activity ISO RGD:1348437 6480464 diallyl trisulfide results in decreased activity of MMP9 protein CTD PMID:24084732 diallyl trisulfide decreases expression ISO RGD:1348437 6480464 diallyl trisulfide results in decreased expression of MMP9 mRNA, diallyl trisulfide results in decreased expression of MMP9 protein CTD PMID:23430952 more ... diallyl trisulfide multiple interactions ISO RGD:1348437 6480464 diallyl trisulfide results in decreased expression of and results in decreased activity of MMP9 protein more ... CTD PMID:23430952 , PMID:27566995 diarsenic trioxide decreases expression ISO RGD:1348437 6480464 Arsenic Trioxide results in decreased expression of MMP9 mRNA, Arsenic Trioxide results in decreased expression of MMP9 protein CTD PMID:15962302 more ... diarsenic trioxide decreases expression ISO RGD:731911 6480464 Arsenic Trioxide results in decreased expression of MMP9 mRNA, Arsenic Trioxide results in decreased expression of MMP9 protein CTD PMID:23210436 diarsenic trioxide increases expression ISO RGD:1348437 6480464 Arsenic Trioxide results in increased expression of MMP9 more ... CTD PMID:15949266 more ... diarsenic trioxide decreases response to substance ISO RGD:1348437 6480464 MMP9 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:24956101 diarsenic trioxide decreases activity ISO RGD:1348437 6480464 Arsenic Trioxide results in decreased activity of MMP9 protein CTD PMID:21969006 more ... diarsenic trioxide multiple interactions ISO RGD:1348437 6480464 [acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased activity of MMP9 protein more ... CTD PMID:15962302 more ... dibenziodolium multiple interactions ISO RGD:1348437 6480464 diphenyleneiodonium inhibits the reaction [Hydrogen Peroxide results in increased expression of MMP9 mRNA] more ... CTD PMID:19804834 more ... dibenziodolium multiple interactions EXP 6480464 diphenyleneiodonium inhibits the reaction [RELA protein binds to MMP9 promoter] more ... CTD PMID:16213474 , PMID:23774252 dibenziodolium multiple interactions ISO RGD:731911 6480464 diphenyleneiodonium inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] CTD PMID:15557194 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of MMP9 protein CTD PMID:19549552 dicoumarol multiple interactions ISO RGD:1348437 6480464 Dicumarol inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein] more ... CTD PMID:17669387 dieckol decreases expression ISO RGD:1348437 6480464 dieckol results in decreased expression of MMP9 protein CTD PMID:31291034 dieldrin increases expression EXP 6480464 Dieldrin results in increased expression of MMP9 mRNA CTD PMID:23153324 diepoxybutane decreases activity EXP 6480464 diepoxybutane results in decreased activity of MMP9 protein CTD PMID:12242682 dihydroartemisinin multiple interactions ISO RGD:1348437 6480464 dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] more ... CTD PMID:20152819 diisononyl phthalate affects expression ISO RGD:1348437 6480464 diisononyl phthalate affects the expression of MMP9 mRNA CTD PMID:31154059 dimethyl sulfoxide multiple interactions EXP 6480464 [Dimethyl Sulfoxide co-treated with resveratrol] inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein], Dimethyl Sulfoxide inhibits the reaction [Ethanol results in increased activity of MMP9 protein] CTD PMID:17603938 , PMID:26497626 dimethyl sulfoxide increases expression EXP 6480464 Dimethyl Sulfoxide results in increased expression of MMP9 protein CTD PMID:26497626 dimethylarsinic acid increases expression ISO RGD:731911 6480464 Cacodylic Acid results in increased expression of MMP9 mRNA CTD PMID:17441966 dimethylarsinous acid increases expression ISO RGD:1348437 6480464 dimethylarsinous acid results in increased expression of MMP9 mRNA CTD PMID:23876855 diosgenin multiple interactions ISO RGD:1348437 6480464 Diosgenin inhibits the reaction [TNF protein results in increased expression of MMP9 protein] CTD PMID:16331273 diosgenin decreases activity EXP 6480464 Diosgenin results in decreased activity of MMP9 protein CTD PMID:21814480 diosgenin decreases expression EXP 6480464 Diosgenin results in decreased expression of MMP9 mRNA CTD PMID:21814480 dioxygen multiple interactions EXP 6480464 2 more ... CTD PMID:23270704 more ... dioxygen increases expression ISO RGD:1348437 6480464 Oxygen deficiency results in increased expression of MMP9 mRNA, Oxygen deficiency results in increased expression of MMP9 protein CTD PMID:18674879 more ... dioxygen increases activity ISO RGD:1348437 6480464 Oxygen deficiency results in increased activity of MMP9 protein CTD PMID:18674879 dioxygen multiple interactions ISO RGD:1348437 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 mRNA more ... CTD PMID:18674879 more ... dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of MMP9 mRNA, Oxygen deficiency results in increased expression of MMP9 protein CTD PMID:23270704 more ... dioxygen multiple interactions ISO RGD:731911 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased activity of MMP9 protein more ... CTD PMID:16806698 more ... disodium selenite multiple interactions EXP 6480464 Sodium Selenite inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein] CTD PMID:19933942 disodium selenite multiple interactions ISO RGD:731911 6480464 [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of MMP9 mRNA CTD PMID:23274088 disulfiram decreases expression ISO RGD:1348437 6480464 Disulfiram results in decreased expression of MMP9 CTD PMID:18047805 divanadium pentaoxide increases expression ISO RGD:731911 6480464 vanadium pentoxide results in increased expression of MMP9 protein CTD PMID:18059072 donepezil hydrochloride decreases expression ISO RGD:731911 6480464 Donepezil results in decreased expression of MMP9 protein CTD PMID:21750701 donepezil hydrochloride multiple interactions ISO RGD:731911 6480464 Donepezil results in decreased expression of and results in decreased activity of MMP9 protein CTD PMID:21750701 doxorubicin affects expression ISO RGD:1348437 6480464 Doxorubicin affects the expression of MMP9 mRNA CTD PMID:15205334 doxorubicin decreases expression ISO RGD:1348437 6480464 Doxorubicin results in decreased expression of MMP9 mRNA CTD PMID:29803840 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of MMP9 mRNA, Doxorubicin results in decreased expression of MMP9 protein CTD PMID:19357873 , PMID:19801496 doxorubicin increases expression ISO RGD:731911 6480464 Doxorubicin results in increased expression of MMP9 mRNA CTD PMID:16455267 , PMID:19286953 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of MMP9 mRNA, Doxorubicin results in increased expression of MMP9 protein CTD PMID:16213474 more ... doxorubicin increases activity EXP 6480464 Doxorubicin results in increased activity of MMP9 protein CTD PMID:16213474 , PMID:25816614 doxorubicin multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA] more ... CTD PMID:16213474 more ... doxorubicin multiple interactions ISO RGD:731911 6480464 Doxorubicin inhibits the reaction [Quercetin results in decreased activity of MMP9 protein], tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA] CTD PMID:14593496 , PMID:19286953 doxorubicin decreases response to substance ISO RGD:731911 6480464 MMP9 gene mutant form results in decreased susceptibility to Doxorubicin CTD PMID:20407279 doxorubicin decreases expression ISO RGD:731911 6480464 Doxorubicin results in decreased expression of MMP9 mRNA CTD PMID:15033991 doxycycline multiple interactions ISO RGD:731911 6480464 Doxycycline inhibits the reaction [Isoproterenol results in increased activity of MMP9] more ... CTD PMID:15131573 , PMID:18089841 doxycycline multiple interactions EXP 6480464 Doxycycline inhibits the reaction [AGT protein modified form results in increased activity of MMP9 protein] CTD PMID:20837116 doxycycline decreases activity EXP 6480464 Doxycycline results in decreased activity of MMP9 protein CTD PMID:20837116 doxycycline multiple interactions ISO RGD:1348437 6480464 Doxycycline inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein], Doxycycline inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] CTD PMID:17498959 , PMID:19375915 doxycycline decreases expression ISO RGD:731911 6480464 Doxycycline results in decreased expression of MMP9 protein CTD PMID:18178469 EC 3.1.1.4 (phospholipase A2) inhibitor multiple interactions ISO RGD:1348437 6480464 Phospholipase A2 Inhibitors inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA], Phospholipase A2 Inhibitors inhibits the reaction [IL1B protein results in increased secretion of MMP9 protein] CTD PMID:19765281 EC 3.1.1.4 (phospholipase A2) inhibitor decreases expression ISO RGD:1348437 6480464 Phospholipase A2 Inhibitors results in decreased expression of MMP9 mRNA CTD PMID:19765281 EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor multiple interactions ISO RGD:1348437 6480464 [Adrenergic beta-Antagonists co-treated with Angiotensin-Converting Enzyme Inhibitors] results in decreased expression of MMP9 protein CTD PMID:21697605 edaravone multiple interactions EXP 6480464 Edaravone inhibits the reaction [PLAT protein results in increased expression of and results in increased activity of MMP9 protein], Edaravone inhibits the reaction [PLAT protein results in increased expression of MMP9 mRNA] CTD PMID:19095969 elemental carbon increases expression ISO RGD:1348437 6480464 Carbon results in increased expression of MMP9 mRNA CTD PMID:26880698 elemental carbon multiple interactions ISO RGD:1348437 6480464 Carbon promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of MMP9 mRNA], lipopolysaccharide, E coli O55-B5 promotes the reaction [Carbon results in increased expression of MMP9 mRNA] CTD PMID:26880698 elemental selenium decreases expression ISO RGD:1348437 6480464 Selenium results in decreased expression of MMP9 mRNA CTD PMID:17390030 embelin decreases expression ISO RGD:1348437 6480464 embelin results in decreased expression of MMP9 protein CTD PMID:24694877 emetine multiple interactions ISO RGD:1348437 6480464 MAPK14 mutant form inhibits the reaction [Emetine results in decreased activity of MMP9 protein] CTD PMID:26332055 emetine decreases expression ISO RGD:1348437 6480464 Emetine results in decreased expression of MMP9 mRNA CTD PMID:26332055 emetine decreases activity ISO RGD:1348437 6480464 Emetine results in decreased activity of MMP9 protein CTD PMID:26332055 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of MMP9 mRNA CTD PMID:29391264 entinostat decreases secretion ISO RGD:1348437 6480464 entinostat results in decreased secretion of MMP9 protein CTD PMID:20421217 entinostat decreases expression ISO RGD:731911 6480464 entinostat results in decreased expression of MMP9 protein CTD PMID:21041383 entinostat increases expression ISO RGD:1348437 6480464 entinostat results in increased expression of MMP9 mRNA CTD PMID:27188386 erlotinib hydrochloride multiple interactions ISO RGD:1348437 6480464 [Erlotinib Hydrochloride co-treated with Arsenic Trioxide] results in decreased expression of MMP9 mRNA CTD PMID:29274334 ethanol multiple interactions EXP 6480464 [Ethanol co-treated with Dietary Fats co-treated with Acetylcysteine] results in increased expression of MMP9 mRNA more ... CTD PMID:16622519 more ... ethanol increases expression ISO RGD:1348437 6480464 Ethanol results in increased expression of MMP9 mRNA CTD PMID:31059573 ethanol increases expression ISO RGD:731911 6480464 Ethanol results in increased expression of MMP9 mRNA CTD PMID:30319688 ethanol increases secretion EXP 6480464 Ethanol results in increased secretion of MMP9 protein CTD PMID:22257724 ethanol increases expression EXP 6480464 Ethanol results in increased expression of MMP9 mRNA, Ethanol results in increased expression of MMP9 protein CTD PMID:17603938 more ... etodolac decreases expression ISO RGD:731911 6480464 Etodolac results in decreased expression of MMP9 mRNA CTD PMID:16391837 eugenol multiple interactions EXP 6480464 Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP9 protein], Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MMP9 mRNA] CTD PMID:20434464 eugenol decreases expression ISO RGD:1348437 6480464 Eugenol results in decreased expression of MMP9 mRNA CTD PMID:30518369 everolimus multiple interactions ISO RGD:1348437 6480464 Everolimus inhibits the reaction [4-cresol results in increased expression of MMP9 protein] CTD PMID:30910523 Evodiamine multiple interactions ISO RGD:1348437 6480464 evodiamine inhibits the reaction [TNF protein results in increased expression of MMP9 protein] CTD PMID:15710601 excitatory amino acid agonist increases expression ISO RGD:731911 6480464 Excitatory Amino Acid Agonists results in increased expression of MMP9 protein CTD PMID:26655082 famotidine multiple interactions EXP 6480464 Famotidine inhibits the reaction [Ethanol results in increased expression of and results in increased activity of MMP9 protein] more ... CTD PMID:17603938 , PMID:22257724 farnesyl diphosphate multiple interactions EXP 6480464 farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]], farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]] CTD PMID:19299917 farrerol multiple interactions EXP 6480464 farrerol inhibits the reaction [Glucose results in decreased expression of MMP9 mRNA], farrerol inhibits the reaction [Glucose results in decreased expression of MMP9 protein] CTD PMID:31838053 fasudil hydrochloride affects expression ISO RGD:731911 6480464 fasudil affects the expression of MMP9 mRNA CTD PMID:26120273 fenofibrate multiple interactions ISO RGD:1348437 6480464 Fenofibrate inhibits the reaction [Dinoprostone results in increased expression of MMP9 mRNA] more ... CTD PMID:19880272 , PMID:21075133 fenofibrate decreases expression ISO RGD:1348437 6480464 Fenofibrate results in decreased expression of MMP9 protein CTD PMID:25545733 Fexofenadine hydrochloride multiple interactions ISO RGD:1348437 6480464 fexofenadine inhibits the reaction [TNF protein results in increased activity of MMP9 protein] more ... CTD PMID:15663564 fingolimod hydrochloride multiple interactions ISO RGD:1348437 6480464 Fingolimod Hydrochloride inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 mRNA], Fingolimod Hydrochloride inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 protein] CTD PMID:25980589 fisetin multiple interactions ISO RGD:1348437 6480464 fisetin inhibits the reaction [Silicon Dioxide results in increased expression of MMP9 mRNA], fisetin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of and results in increased activity of MMP9 protein] CTD PMID:22931364 , PMID:31606474 fisetin multiple interactions ISO RGD:731911 6480464 HMOX1 protein promotes the reaction [fisetin results in decreased expression of MMP9 protein] more ... CTD PMID:30076913 fisetin decreases expression ISO RGD:731911 6480464 fisetin results in decreased expression of MMP9 mRNA, fisetin results in decreased expression of MMP9 protein CTD PMID:30076913 flavonoids decreases expression ISO RGD:1348437 6480464 Flavonoids results in decreased expression of MMP9 mRNA, Flavonoids results in decreased expression of MMP9 protein CTD PMID:24036141 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of MMP9 mRNA CTD PMID:18035473 flucythrinate affects binding ISO RGD:1348437 6480464 flucythrinate binds to MMP9 protein CTD PMID:32278787 fluoxetine multiple interactions ISO RGD:731911 6480464 Fluoxetine inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA] CTD PMID:15312242 fluoxetine multiple interactions EXP 6480464 [9 more ... CTD PMID:31332895 fluoxetine decreases activity EXP 6480464 Fluoxetine results in decreased activity of MMP9 protein CTD PMID:21966942 flurbiprofen multiple interactions ISO RGD:1348437 6480464 [[Flurbiprofen results in increased expression of TIMP1 protein] which results in decreased expression of MMP9 mRNA] which results in decreased degradation of HPGD protein, [Flurbiprofen results in increased expression of TIMP1 protein] which results in decreased expression of MMP9 mRNA CTD PMID:19501039 flurbiprofen decreases expression ISO RGD:1348437 6480464 Flurbiprofen results in decreased expression of MMP9 mRNA CTD PMID:19501039 flutamide multiple interactions EXP 6480464 daidzein inhibits the reaction [Flutamide results in increased expression of MMP9 mRNA] CTD PMID:23135684 flutamide increases expression EXP 6480464 Flutamide results in increased expression of MMP9 mRNA CTD PMID:23135684 fluvalinate affects binding ISO RGD:1348437 6480464 fluvalinate binds to MMP9 protein CTD PMID:32278787 fluvastatin multiple interactions ISO RGD:1348437 6480464 Amitrole inhibits the reaction [fluvastatin results in decreased expression of MMP9 mRNA] CTD PMID:24964743 fluvastatin decreases expression ISO RGD:1348437 6480464 fluvastatin results in decreased expression of MMP9 mRNA CTD PMID:24964743 folic acid multiple interactions EXP 6480464 Dizocilpine Maleate inhibits the reaction [Folic Acid deficiency results in decreased expression of MMP9 mRNA] CTD PMID:20406136 folic acid increases secretion ISO RGD:1348437 6480464 Folic Acid results in increased secretion of MMP9 protein CTD PMID:21349824 folic acid multiple interactions ISO RGD:731911 6480464 [Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MMP9 mRNA, Folic Acid inhibits the reaction [AGT protein results in increased expression of and results in increased activity of MMP9 protein] CTD PMID:23439872 , PMID:24386282 folic acid decreases expression EXP 6480464 Folic Acid deficiency results in decreased expression of MMP9 mRNA CTD PMID:20406136 folic acid decreases activity EXP 6480464 Folic Acid deficiency results in decreased activity of MMP9 protein CTD PMID:20406136 formoterol fumarate multiple interactions EXP 6480464 Budesonide promotes the reaction [Formoterol Fumarate inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein]] more ... CTD PMID:20826145 , PMID:25313925 fosinopril decreases expression EXP 6480464 Fosinopril results in decreased expression of MMP9 mRNA, Fosinopril results in decreased expression of MMP9 protein CTD PMID:21051829 fosinopril multiple interactions EXP 6480464 [Valsartan co-treated with Fosinopril] results in decreased expression of MMP9 mRNA, [Valsartan co-treated with Fosinopril] results in decreased expression of MMP9 protein CTD PMID:21051829 fructose increases expression ISO RGD:1348437 6480464 Fructose results in increased expression of MMP9 mRNA CTD PMID:31655124 fucoidan decreases expression ISO RGD:1348437 6480464 fucoidan results in decreased expression of MMP9 CTD PMID:24333868 fucoidan multiple interactions ISO RGD:1348437 6480464 wortmannin inhibits the reaction [fucoidan results in decreased expression of MMP9] CTD PMID:24333868 fulvestrant multiple interactions ISO RGD:1348437 6480464 fulvestrant inhibits the reaction [bisphenol A results in increased expression of MMP9 mRNA] more ... CTD PMID:19956873 more ... fumigaclavine C decreases expression ISO RGD:731911 6480464 fumigaclavine C results in decreased expression of MMP9 mRNA CTD PMID:16023606 fumigaclavine C decreases activity ISO RGD:731911 6480464 fumigaclavine C results in decreased activity of MMP9 protein CTD PMID:16023606 gadolinium trichloride increases expression EXP 6480464 gadolinium chloride results in increased expression of MMP9 mRNA CTD PMID:12493575 gadolinium trichloride multiple interactions EXP 6480464 SB 203580 inhibits the reaction [gadolinium chloride results in increased expression of MMP9 mRNA] CTD PMID:12493575 galactose multiple interactions EXP 6480464 fruit extract, Alpinia oxyphylla inhibits the reaction [Galactose results in increased expression of and results in increased activity of MMP9 protein], Galactose results in increased expression of and results in increased activity of MMP9 protein CTD PMID:30367734 gallic acid decreases expression ISO RGD:731911 6480464 Gallic Acid results in decreased expression of MMP9 mRNA CTD PMID:16304905 gallic acid multiple interactions ISO RGD:1348437 6480464 [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA] more ... CTD PMID:27087131 , PMID:27634460 gallic acid multiple interactions EXP 6480464 Gallic Acid inhibits the reaction [ALB modified form results in increased expression of MMP9 mRNA], Gallic Acid inhibits the reaction [ALB modified form results in increased expression of MMP9 protein] CTD PMID:24309158 gallic acid decreases activity ISO RGD:1348437 6480464 Gallic Acid results in decreased activity of MMP9 protein CTD PMID:22387266 gallic acid decreases expression ISO RGD:1348437 6480464 Gallic Acid results in decreased expression of MMP9 mRNA, Gallic Acid results in decreased expression of MMP9 protein CTD PMID:22387266 gefitinib multiple interactions ISO RGD:1348437 6480464 gefitinib inhibits the reaction [EGF protein results in increased expression of MMP9 protein] more ... CTD PMID:23127547 , PMID:27087131 gefitinib multiple interactions EXP 6480464 gefitinib inhibits the reaction [HBEGF protein inhibits the reaction [sodium arsenite results in increased expression of and results in increased secretion of and results in increased activity of MMP9 protein]] CTD PMID:29228391 gefitinib multiple interactions ISO RGD:731911 6480464 gefitinib inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] CTD PMID:15841081 gemcitabine multiple interactions ISO RGD:731911 6480464 [Curcumin co-treated with gemcitabine] results in decreased expression of MMP9 protein CTD PMID:17440100 gemcitabine multiple interactions ISO RGD:1348437 6480464 [gemcitabine co-treated with IFNA2 protein] results in increased expression of MMP9 protein CTD PMID:12738744 Genipin multiple interactions ISO RGD:1348437 6480464 genipin inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein] CTD PMID:29630948 genistein decreases activity ISO RGD:1348437 6480464 Genistein results in decreased activity of MMP9 protein CTD PMID:16598420 genistein decreases expression ISO RGD:1348437 6480464 Genistein results in decreased expression of MMP9 mRNA, Genistein results in decreased expression of MMP9 protein CTD PMID:15256057 , PMID:15754008 GGTI-2133 multiple interactions EXP 6480464 GGTI-2133 inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA], GGTI-2133 inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein] CTD PMID:19299917 gingerol decreases activity ISO RGD:1348437 6480464 gingerol results in decreased activity of MMP9 protein CTD PMID:17683926 gingerol decreases expression ISO RGD:1348437 6480464 gingerol results in decreased expression of MMP9 mRNA CTD PMID:17683926 ginsenoside C-K decreases secretion ISO RGD:1348437 6480464 ginsenoside M1 results in decreased secretion of MMP9 protein CTD PMID:21875580 glucagon multiple interactions ISO RGD:731911 6480464 Glucagon analog inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of MMP9 mRNA], Glucagon analog inhibits the reaction [LEPR gene mutant form results in increased expression of MMP9 mRNA] CTD PMID:29988851 glucose multiple interactions EXP 6480464 [Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of MMP9 protein] more ... CTD PMID:22467055 , PMID:31838053 glucose increases expression ISO RGD:1348437 6480464 Glucose results in increased expression of MMP9 mRNA CTD PMID:28478229 , PMID:31655124 glucose decreases expression EXP 6480464 Glucose results in decreased expression of MMP9 protein CTD PMID:31838053 glucose multiple interactions ISO RGD:1348437 6480464 [Glucose co-treated with Resveratrol] results in decreased expression of MMP9 mRNA more ... CTD PMID:24064760 more ... glucose multiple interactions ISO RGD:731911 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA more ... CTD PMID:24659233 , PMID:24682241 glutathione affects binding ISO RGD:1348437 6480464 Glutathione binds to MMP9 protein CTD PMID:17015178 glutathione multiple interactions ISO RGD:731911 6480464 Glutathione inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of MMP9 protein] CTD PMID:21722719 glutathione decreases secretion ISO RGD:1348437 6480464 Glutathione results in decreased secretion of MMP9 protein CTD PMID:15147517 glutathione multiple interactions ISO RGD:1348437 6480464 Glutathione inhibits the reaction [4-aminophenylmercuriacetate results in increased activity of MMP9 protein] more ... CTD PMID:17015178 , PMID:17640567 glycitein multiple interactions ISO RGD:1348437 6480464 glycitein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] CTD PMID:20188714 glycitein decreases expression ISO RGD:1348437 6480464 glycitein results in decreased expression of MMP9 mRNA, glycitein results in decreased expression of MMP9 protein CTD PMID:20188714 glycyrrhetinate multiple interactions ISO RGD:1348437 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in increased activity of MMP9 protein], 18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] CTD PMID:24613819 glycyrrhetinic acid multiple interactions ISO RGD:1348437 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in increased activity of MMP9 protein], 18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] CTD PMID:24613819 Goe 6976 multiple interactions ISO RGD:1348437 6480464 Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] more ... CTD PMID:19804834 more ... gold atom multiple interactions ISO RGD:1348437 6480464 [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA] more ... CTD PMID:27634460 gold(0) multiple interactions ISO RGD:1348437 6480464 [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA] more ... CTD PMID:27634460 graphite increases expression EXP 6480464 Graphite results in increased expression of MMP9 mRNA CTD PMID:29933104 guggulsterone multiple interactions ISO RGD:1348437 6480464 pregna-4 more ... CTD PMID:15322087 GW 501516 multiple interactions ISO RGD:1348437 6480464 BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]] more ... CTD PMID:23737761 heparin decreases activity ISO RGD:1348437 6480464 Heparin results in decreased activity of MMP9 protein CTD PMID:10958381 heparin increases expression ISO RGD:731911 6480464 Heparin results in increased expression of MMP9 mRNA, Heparin results in increased expression of MMP9 protein CTD PMID:14630814 , PMID:16190367 heparin multiple interactions ISO RGD:731911 6480464 Heparin results in increased metabolism of and results in increased activity of MMP9 protein CTD PMID:14630814 heptachlor increases expression EXP 6480464 Heptachlor results in increased expression of MMP9 mRNA CTD PMID:23153324 hesperidin multiple interactions ISO RGD:1348437 6480464 Hesperidin inhibits the reaction [Acetaldehyde results in increased expression of and results in increased activity of MMP9 protein] more ... CTD PMID:19110045 , PMID:20138977 hesperidin decreases secretion ISO RGD:1348437 6480464 Hesperidin results in decreased secretion of MMP9 protein CTD PMID:19110045 hexachlorobenzene increases expression EXP 6480464 Hexachlorobenzene results in increased expression of MMP9 mRNA CTD PMID:15159207 hexachlorobenzene multiple interactions ISO RGD:1348437 6480464 alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased secretion of and results in increased activity of MMP9 protein] more ... CTD PMID:23462309 hexachlorobenzene increases expression ISO RGD:1348437 6480464 Hexachlorobenzene results in increased expression of MMP9 mRNA CTD PMID:23462309 hexanal increases secretion ISO RGD:1348437 6480464 n-hexanal results in increased secretion of MMP9 protein CTD PMID:28947239 high-density lipoprotein cholesterol multiple interactions ISO RGD:1348437 6480464 [Arsenic results in increased expression of and results in increased secretion of MMP9 protein] which results in decreased abundance of Cholesterol, HDL CTD PMID:26637202 hinokiflavone decreases expression ISO RGD:1348437 6480464 hinokiflavone results in decreased expression of MMP9 protein CTD PMID:29635122 hinokiflavone decreases expression ISO RGD:731911 6480464 hinokiflavone results in decreased expression of MMP9 mRNA, hinokiflavone results in decreased expression of MMP9 protein CTD PMID:30575109 homocysteine multiple interactions ISO RGD:1348437 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Homocysteine results in increased activity of MMP9 protein] more ... CTD PMID:16251475 homocysteine multiple interactions ISO RGD:731911 6480464 Homocysteine results in increased activity of and results in increased expression of MMP9 protein CTD PMID:22326992 homocysteine increases expression ISO RGD:1348437 6480464 Homocysteine results in increased expression of MMP9 protein CTD PMID:16251475 homocysteine increases activity ISO RGD:1348437 6480464 Homocysteine results in increased activity of MMP9 protein CTD PMID:16251475 homocysteine multiple interactions EXP 6480464 Dizocilpine Maleate inhibits the reaction [Homocysteine analog results in decreased expression of MMP9 protein] CTD PMID:20406136 homocysteine decreases expression EXP 6480464 Homocysteine analog results in decreased expression of MMP9 protein CTD PMID:20406136 hyaluronic acid affects activity ISO RGD:731911 6480464 Hyaluronic Acid affects the activity of MMP9 protein CTD PMID:15597151 hydrogen peroxide increases secretion ISO RGD:1348437 6480464 Hydrogen Peroxide results in increased secretion of MMP9 protein CTD PMID:15531749 hydrogen peroxide multiple interactions ISO RGD:1348437 6480464 3-methyladenine inhibits the reaction [Hydrogen Peroxide results in decreased expression of MMP9 protein] more ... CTD PMID:26514923 more ... hydrogen peroxide decreases expression ISO RGD:1348437 6480464 Hydrogen Peroxide results in decreased expression of MMP9 mRNA, Hydrogen Peroxide results in decreased expression of MMP9 protein CTD PMID:26339600 , PMID:32043704 hydrogen peroxide increases expression ISO RGD:1348437 6480464 Hydrogen Peroxide results in increased expression of MMP9 mRNA, Hydrogen Peroxide results in increased expression of MMP9 protein CTD PMID:15531749 more ... hydrogen peroxide increases activity ISO RGD:1348437 6480464 Hydrogen Peroxide results in increased activity of MMP9 protein CTD PMID:15531749 hydrogen sulfide multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [Hydrogen Sulfide results in increased expression of MMP9 mRNA] more ... CTD PMID:24722316 hydrogen sulfide increases expression EXP 6480464 Hydrogen Sulfide results in increased expression of MMP9 mRNA, Hydrogen Sulfide results in increased expression of MMP9 protein CTD PMID:24722316 hydroquinone multiple interactions ISO RGD:1348437 6480464 hydroquinone inhibits the reaction [Dicumarol inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]] more ... CTD PMID:17669387 , PMID:26807887 hydroquinone increases expression ISO RGD:1348437 6480464 hydroquinone results in increased expression of MMP9 mRNA CTD PMID:26807887 hydroquinone increases secretion ISO RGD:1348437 6480464 hydroquinone results in increased secretion of MMP9 protein CTD PMID:26807887 hydroxamic acid multiple interactions ISO RGD:1348437 6480464 Hydroxamic Acids inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein], Hydroxamic Acids inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] CTD PMID:27163855 hydroxysafflor yellow A multiple interactions EXP 6480464 hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in increased expression of MMP9 protein]] more ... CTD PMID:24192212 hydroxysafflor yellow A decreases expression ISO RGD:1348437 6480464 hydroxysafflor yellow A results in decreased expression of MMP9 protein CTD PMID:32705535 hydroxytyrosol multiple interactions ISO RGD:1348437 6480464 3 more ... CTD PMID:22595400 ibuprofen multiple interactions ISO RGD:1348437 6480464 Ibuprofen inhibits the reaction [EGF protein results in increased activity of MMP9 protein], Ibuprofen inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA] CTD PMID:16340751 ibuprofen multiple interactions EXP 6480464 [Ibuprofen co-treated with Carbon Tetrachloride] results in increased expression of MMP9 protein CTD PMID:21360558 ICI 118551 decreases expression ISO RGD:1348437 6480464 ICI 118551 results in decreased expression of MMP9 mRNA, ICI 118551 results in decreased expression of MMP9 protein CTD PMID:20424515 ICI 118551 decreases secretion ISO RGD:1348437 6480464 ICI 118551 results in decreased secretion of MMP9 protein CTD PMID:20424515 idebenone multiple interactions EXP 6480464 idebenone inhibits the reaction [Streptozocin results in increased expression of MMP9 protein] CTD PMID:28648635 idebenone decreases expression EXP 6480464 idebenone results in decreased expression of MMP9 protein CTD PMID:28648635 ifosfamide multiple interactions ISO RGD:731911 6480464 [Ifosfamide co-treated with IFNA2] affects the expression of MMP9 mRNA more ... CTD PMID:15659795 ifosfamide decreases activity ISO RGD:731911 6480464 Ifosfamide results in decreased activity of MMP9 protein CTD PMID:15659795 ifosfamide affects expression ISO RGD:731911 6480464 Ifosfamide affects the expression of MMP9 mRNA CTD PMID:15659795 imiquimod decreases activity ISO RGD:731911 6480464 imiquimod results in decreased activity of MMP9 protein CTD PMID:14708627 indinavir multiple interactions EXP 6480464 Indinavir inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] more ... CTD PMID:14662518 indole-3-methanol multiple interactions ISO RGD:1348437 6480464 indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of MMP9 protein] CTD PMID:15811958 indole-3-methanol decreases expression ISO RGD:731911 6480464 indole-3-carbinol results in decreased expression of MMP9 protein CTD PMID:29775573 indometacin multiple interactions ISO RGD:731911 6480464 [Indomethacin co-treated with Medroxyprogesterone Acetate] results in decreased activity of MMP9 protein more ... CTD PMID:14515793 , PMID:16537180 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of MMP9 protein CTD PMID:29523851 indometacin multiple interactions EXP 6480464 Indomethacin results in increased expression of and results in increased secretion of and results in increased activity of MMP9 protein more ... CTD PMID:16150113 more ... indometacin decreases activity EXP 6480464 Indomethacin results in decreased activity of MMP9 protein CTD PMID:10231640 indometacin increases activity EXP 6480464 Indomethacin results in increased activity of MMP9 protein CTD PMID:10878458 indometacin decreases activity ISO RGD:731911 6480464 Indomethacin results in decreased activity of MMP9 protein CTD PMID:16537180 indometacin multiple interactions ISO RGD:1348437 6480464 Indomethacin results in decreased expression of and results in decreased activity of MMP9 protein CTD PMID:11719597 ipratropium multiple interactions EXP 6480464 Ipratropium promotes the reaction [Formoterol Fumarate inhibits the reaction [Cadmium results in increased activity of MMP9 protein]] CTD PMID:20826145 irbesartan multiple interactions EXP 6480464 Irbesartan inhibits the reaction [Indomethacin results in increased expression of MMP9 protein] CTD PMID:29523851 irinotecan increases expression ISO RGD:1348437 6480464 Irinotecan metabolite results in increased expression of MMP9 mRNA, Irinotecan results in increased expression of MMP9 mRNA CTD PMID:15956246 isoliquiritigenin multiple interactions ISO RGD:1348437 6480464 20-hydroxyeicosa-5(Z) more ... CTD PMID:25094029 isoliquiritigenin decreases expression ISO RGD:1348437 6480464 isoliquiritigenin results in decreased expression of MMP9 mRNA, isoliquiritigenin results in decreased expression of MMP9 protein CTD PMID:25094029 isoprenaline increases expression ISO RGD:1348437 6480464 Isoproterenol results in increased expression of MMP9 mRNA CTD PMID:16574429 , PMID:24929186 isoprenaline multiple interactions EXP 6480464 CPU0213 inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA], pimagedine inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA] CTD PMID:18594475 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of MMP9 mRNA CTD PMID:18594475 isoprenaline increases activity ISO RGD:731911 6480464 Isoproterenol results in increased activity of MMP9 CTD PMID:18089841 isoprenaline multiple interactions ISO RGD:731911 6480464 Doxycycline inhibits the reaction [Isoproterenol results in increased activity of MMP9] CTD PMID:18089841 isoprenaline multiple interactions ISO RGD:1348437 6480464 Propranolol inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA] CTD PMID:16574429 isotretinoin multiple interactions ISO RGD:1348437 6480464 Isotretinoin inhibits the reaction [Arachidonic Acid results in increased expression of MMP9 mRNA], Isotretinoin inhibits the reaction [Arachidonic Acid results in increased secretion of MMP9 protein] CTD PMID:16185265 isotretinoin decreases expression ISO RGD:1348437 6480464 Isotretinoin results in decreased expression of MMP9 protein CTD PMID:16185265 juglone multiple interactions ISO RGD:1348437 6480464 [juglone co-treated with Ascorbic Acid] results in decreased expression of MMP9 mRNA CTD PMID:29992683 kainic acid increases activity ISO RGD:731911 6480464 Kainic Acid results in increased activity of MMP9 protein CTD PMID:30772382 kainic acid multiple interactions ISO RGD:731911 6480464 MMP9 protein affects the reaction [Kainic Acid results in decreased expression of NCAM1 protein modified form] CTD PMID:30772382 L-ascorbic acid multiple interactions ISO RGD:1348437 6480464 [juglone co-treated with Ascorbic Acid] results in decreased expression of MMP9 mRNA CTD PMID:29992683 L-methionine multiple interactions ISO RGD:731911 6480464 3 more ... CTD PMID:22915297 , PMID:28973532 lead diacetate increases expression ISO RGD:731911 6480464 lead acetate results in increased expression of MMP9 mRNA CTD PMID:20542052 letrozole multiple interactions ISO RGD:1348437 6480464 letrozole inhibits the reaction [sodium arsenite results in increased activity of and results in increased secretion of MMP9 protein] CTD PMID:24068038 leukotriene B4 increases expression ISO RGD:731911 6480464 Leukotriene B4 results in increased expression of MMP9 protein CTD PMID:19837106 leukotriene B4 multiple interactions ISO RGD:731911 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Leukotriene B4 results in increased expression of MMP9 protein], SB 203580 inhibits the reaction [Leukotriene B4 results in increased expression of MMP9 protein] CTD PMID:19837106 leukotriene C4 multiple interactions ISO RGD:731911 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Leukotriene C4 results in increased expression of MMP9 protein], SB 203580 inhibits the reaction [Leukotriene C4 results in increased expression of MMP9 protein] CTD PMID:19837106 leukotriene C4 increases expression ISO RGD:731911 6480464 Leukotriene C4 results in increased expression of MMP9 protein CTD PMID:19837106 leukotriene D4 multiple interactions ISO RGD:731911 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Leukotriene D4 results in increased expression of MMP9 protein], SB 203580 inhibits the reaction [Leukotriene D4 results in increased expression of MMP9 protein] CTD PMID:19837106 leukotriene D4 increases expression ISO RGD:731911 6480464 Leukotriene D4 results in increased expression of MMP9 protein CTD PMID:19837106 leuprolide decreases expression EXP 6480464 Leuprolide results in decreased expression of MMP9 protein CTD PMID:25462211 leuprolide multiple interactions EXP 6480464 Leuprolide inhibits the reaction [Resveratrol results in decreased expression of MMP9 protein], Resveratrol inhibits the reaction [Leuprolide results in decreased expression of MMP9 protein] CTD PMID:25462211 linalool increases expression ISO RGD:1348437 6480464 linalool results in increased expression of MMP9 mRNA CTD PMID:26703569 linoleic acid multiple interactions EXP 6480464 [Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of MMP9 protein], Linoleic Acid affects the reaction [Azoxymethane affects the expression of MMP9 protein] CTD PMID:22467055 linoleic acid decreases expression ISO RGD:1348437 6480464 Linoleic Acid results in decreased expression of MMP9 mRNA CTD PMID:23288142 linoleic acid multiple interactions ISO RGD:1348437 6480464 Linoleic Acid results in decreased expression of and results in decreased activity of MMP9 protein CTD PMID:23288142 lipoarabinomannan increases activity ISO RGD:731911 6480464 lipoarabinomannan results in increased activity of MMP9 protein CTD PMID:11839551 lipopolysaccharide multiple interactions ISO RGD:1348437 6480464 Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein] more ... CTD PMID:17038636 more ... lipopolysaccharide affects expression ISO RGD:731911 6480464 Lipopolysaccharides affects the expression of MMP9 mRNA CTD PMID:30942577 lipopolysaccharide increases secretion ISO RGD:731911 6480464 Lipopolysaccharides results in increased secretion of MMP9 protein CTD PMID:21200322 , PMID:29743444 lipopolysaccharide increases expression ISO RGD:731911 6480464 Lipopolysaccharides results in increased expression of MMP9 mRNA, Lipopolysaccharides results in increased expression of MMP9 protein CTD PMID:15557194 more ... lipopolysaccharide increases secretion EXP 6480464 Lipopolysaccharides results in increased secretion of MMP9 protein CTD PMID:14662518 , PMID:21362633 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of MMP9 mRNA, Lipopolysaccharides results in increased expression of MMP9 protein CTD PMID:14662518 more ... lipopolysaccharide multiple interactions EXP 6480464 2 more ... CTD PMID:14662518 more ... lipopolysaccharide multiple interactions ISO RGD:731911 6480464 [bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of MMP9 mRNA more ... CTD PMID:15259001 more ... lipopolysaccharide increases secretion ISO RGD:1348437 6480464 Lipopolysaccharides results in increased secretion of MMP9 protein CTD PMID:21075133 lipopolysaccharide increases expression ISO RGD:1348437 6480464 Lipopolysaccharides results in increased expression of MMP9 mRNA, Lipopolysaccharides results in increased expression of MMP9 protein CTD PMID:17038636 more ... lipopolysaccharide increases activity ISO RGD:1348437 6480464 Lipopolysaccharides results in increased activity of MMP9 protein CTD PMID:22102721 liquiritigenin multiple interactions EXP 6480464 liquiritigenin inhibits the reaction [Monocrotaline results in increased expression of MMP9 protein] CTD PMID:29908794 , PMID:31589899 liquiritin multiple interactions EXP 6480464 liquiritin inhibits the reaction [Monocrotaline results in increased expression of MMP9 protein] CTD PMID:29908794 , PMID:31589899 lithocholic acid decreases expression ISO RGD:1348437 6480464 Lithocholic Acid results in decreased expression of MMP9 protein CTD PMID:21224350 lonafarnib multiple interactions ISO RGD:1348437 6480464 lonafarnib inhibits the reaction [TNF protein results in increased expression of MMP9 protein] CTD PMID:15090542 losartan decreases expression EXP 6480464 Losartan results in decreased expression of MMP9 mRNA CTD PMID:18971572 losartan multiple interactions EXP 6480464 Losartan inhibits the reaction [Paraquat results in increased expression of MMP9 mRNA] CTD PMID:25233898 losartan multiple interactions ISO RGD:731911 6480464 Losartan inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] CTD PMID:23585870 lovastatin decreases expression ISO RGD:1348437 6480464 Lovastatin results in decreased expression of MMP9 protein CTD PMID:19360310 luteolin increases expression ISO RGD:1348437 6480464 Luteolin results in increased expression of MMP9 protein CTD PMID:10556937 luteolin multiple interactions ISO RGD:731911 6480464 Luteolin inhibits the reaction [Carbon Tetrachloride results in decreased expression of MMP9 protein] CTD PMID:19747501 luteolin decreases secretion ISO RGD:1348437 6480464 Luteolin results in decreased secretion of MMP9 protein CTD PMID:15135307 luteolin multiple interactions ISO RGD:1348437 6480464 Luteolin analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] more ... CTD PMID:15135307 more ... LY294002 multiple interactions ISO RGD:1348437 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of MMP9 mRNA] more ... CTD PMID:17560598 more ... LY294002 multiple interactions ISO RGD:731911 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of MMP9 mRNA], 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] CTD PMID:19401153 , PMID:19962414 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA], 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein] CTD PMID:19299917 LY294002 decreases expression ISO RGD:1348437 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of MMP9 mRNA, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of MMP9 protein CTD PMID:18424783 , PMID:23566884 LY294002 decreases expression ISO RGD:731911 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of MMP9 mRNA CTD PMID:19393235 , PMID:22326785 LY294002 decreases activity ISO RGD:731911 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased activity of MMP9 protein CTD PMID:19393235 , PMID:22326785 Magnolol decreases expression ISO RGD:1348437 6480464 magnolol results in decreased expression of MMP9 protein CTD PMID:31714653 manganese(II) chloride multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [manganese chloride results in increased expression of and results in increased secretion of MMP9 protein] more ... CTD PMID:23811825 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of MMP9 mRNA CTD PMID:23811825 mangiferin decreases expression ISO RGD:1348437 6480464 mangiferin results in decreased expression of MMP9 mRNA, mangiferin results in decreased expression of MMP9 protein CTD PMID:22465218 , PMID:23707762 mangiferin multiple interactions ISO RGD:731911 6480464 mangiferin inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 protein] CTD PMID:27125760 mangiferin multiple interactions ISO RGD:1348437 6480464 mangiferin results in decreased expression of and results in decreased secretion of MMP9 protein CTD PMID:22465218 mangiferin decreases activity ISO RGD:1348437 6480464 mangiferin results in decreased activity of MMP9 protein CTD PMID:22465218 mechlorethamine multiple interactions ISO RGD:731911 6480464 MPO gene mutant form inhibits the reaction [Mechlorethamine results in increased expression of MMP9], SFTPD gene mutant form promotes the reaction [Mechlorethamine results in increased expression of MMP9 protein] CTD PMID:24631667 , PMID:30060251 mechlorethamine multiple interactions EXP 6480464 Valproic Acid inhibits the reaction [Mechlorethamine results in increased expression of MMP9 mRNA] CTD PMID:28184907 mechlorethamine increases expression ISO RGD:731911 6480464 Mechlorethamine results in increased expression of MMP9, Mechlorethamine results in increased expression of MMP9 protein CTD PMID:24631667 more ... mechlorethamine increases expression EXP 6480464 Mechlorethamine results in increased expression of MMP9 mRNA, Mechlorethamine results in increased expression of MMP9 protein CTD PMID:20883710 more ... medroxyprogesterone acetate multiple interactions ISO RGD:731911 6480464 [Indomethacin co-treated with Medroxyprogesterone Acetate] results in decreased activity of MMP9 protein CTD PMID:16537180 medroxyprogesterone acetate decreases expression ISO RGD:1348437 6480464 Medroxyprogesterone Acetate results in decreased expression of MMP9 mRNA CTD PMID:20843944 medroxyprogesterone acetate decreases activity ISO RGD:731911 6480464 Medroxyprogesterone Acetate results in decreased activity of MMP9 protein CTD PMID:16537180 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Indomethacin results in increased expression of and results in increased secretion of MMP9 protein] CTD PMID:16150113 melittin multiple interactions ISO RGD:1348437 6480464 Melitten inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] more ... CTD PMID:19969058 more ... menadione decreases expression ISO RGD:1348437 6480464 Vitamin K 3 results in decreased expression of MMP9 protein CTD PMID:31238027 mercury atom affects response to substance ISO RGD:1348437 6480464 MMP9 promoter polymorphism affects the susceptibility to Mercury CTD PMID:20554312 mercury(0) affects response to substance ISO RGD:1348437 6480464 MMP9 promoter polymorphism affects the susceptibility to Mercury CTD PMID:20554312 metformin multiple interactions ISO RGD:1348437 6480464 Metformin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] more ... CTD PMID:20590612 metformin multiple interactions ISO RGD:731911 6480464 Metformin inhibits the reaction [IL13 protein results in increased expression of MMP9 mRNA] CTD PMID:26497364 metformin decreases expression ISO RGD:1348437 6480464 Metformin results in decreased expression of MMP9 mRNA CTD PMID:22246099 metformin decreases activity ISO RGD:1348437 6480464 Metformin results in decreased activity of MMP9 protein CTD PMID:20590612 methamphetamine multiple interactions ISO RGD:1348437 6480464 [HIV Envelope Protein gp120 co-treated with Methamphetamine] promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of MMP9 mRNA] more ... CTD PMID:21425912 methamphetamine increases response to substance ISO RGD:731911 6480464 MMP9 protein results in increased susceptibility to Methamphetamine CTD PMID:18198472 methamphetamine increases expression ISO RGD:731911 6480464 Methamphetamine results in increased expression of MMP9 CTD PMID:18766021 methamphetamine increases activity ISO RGD:731911 6480464 Methamphetamine results in increased activity of MMP9 protein CTD PMID:18198472 methotrexate increases expression ISO RGD:1348437 6480464 Methotrexate results in increased expression of MMP9 mRNA CTD PMID:17696278 methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of MMP9 mRNA CTD PMID:29935243 methotrexate multiple interactions ISO RGD:1348437 6480464 [Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of MMP9 mRNA, [Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of MMP9 protein CTD PMID:23146660 methyl caffeate multiple interactions ISO RGD:1348437 6480464 methyl caffeate analog results in decreased expression of and results in decreased activity of MMP9 protein CTD PMID:25481497 methylglyoxal increases expression ISO RGD:1348437 6480464 Pyruvaldehyde results in increased expression of MMP9 protein CTD PMID:28760545 methylglyoxal multiple interactions ISO RGD:731911 6480464 [TNFSF11 protein co-treated with Pyruvaldehyde co-treated with bergenin] results in decreased expression of MMP9 mRNA CTD PMID:31369791 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of MMP9 mRNA, methylmercuric chloride results in increased expression of MMP9 protein CTD PMID:28526320 methylmercury chloride multiple interactions EXP 6480464 methylmercuric chloride inhibits the reaction [ETV4 protein binds to MMP9 promoter] more ... CTD PMID:28526320 methylmercury chloride decreases methylation EXP 6480464 methylmercuric chloride results in decreased methylation of MMP9 promoter CTD PMID:28526320 metoprolol decreases expression ISO RGD:1348437 6480464 Metoprolol results in decreased expression of MMP9 mRNA, Metoprolol results in decreased expression of MMP9 protein CTD PMID:20424515 metoprolol decreases secretion ISO RGD:1348437 6480464 Metoprolol results in decreased secretion of MMP9 protein CTD PMID:20424515 microcystin-LR increases expression ISO RGD:731911 6480464 cyanoginosin LR results in increased expression of MMP9 mRNA, cyanoginosin LR results in increased expression of MMP9 protein CTD PMID:20934494 microcystin-LR decreases expression ISO RGD:731911 6480464 cyanoginosin LR results in decreased expression of MMP9 protein CTD PMID:28189720 mifepristone multiple interactions EXP 6480464 Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein] more ... CTD PMID:15963473 more ... mifepristone multiple interactions ISO RGD:1348437 6480464 Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [sodium bisulfide results in increased expression of MMP9 mRNA]] more ... CTD PMID:18722610 , PMID:24722316 minocycline multiple interactions ISO RGD:731911 6480464 Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 mRNA] more ... CTD PMID:18835858 , PMID:19285099 minocycline decreases activity EXP 6480464 Minocycline results in decreased activity of MMP9 protein CTD PMID:16846501 minocycline decreases expression EXP 6480464 Minocycline results in decreased expression of MMP9 protein CTD PMID:16846501 miquelianin multiple interactions ISO RGD:1348437 6480464 quercetin 3-O-glucuronide inhibits the reaction [Norepinephrine results in increased activity of MMP9 protein], quercetin 3-O-glucuronide inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA] CTD PMID:24929186 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:1348437 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MMP9 protein] more ... CTD PMID:28390675 more ... mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:731911 6480464 mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of MMP9 mRNA] CTD PMID:29718165 mono(2-ethylhexyl) phthalate increases expression ISO RGD:1348437 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 mRNA, mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 protein CTD PMID:28390675 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:1348437 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of MMP9 protein CTD PMID:28416457 monobenzyl phthalate multiple interactions ISO RGD:1348437 6480464 [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased secretion of MMP9 protein CTD PMID:30398665 Monobutylphthalate multiple interactions ISO RGD:1348437 6480464 [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased secretion of MMP9 protein CTD PMID:30398665 monocrotaline multiple interactions ISO RGD:731911 6480464 [TBXA2R protein affects the susceptibility to Monocrotaline] which affects the expression of MMP9 mRNA, TLR4 gene mutant form inhibits the reaction [Monocrotaline results in increased expression of MMP9 protein] CTD PMID:31470032 , PMID:31504964 monocrotaline increases expression ISO RGD:731911 6480464 Monocrotaline results in increased expression of MMP9 protein CTD PMID:31504964 monocrotaline increases expression EXP 6480464 Monocrotaline results in increased expression of MMP9 protein CTD PMID:29908794 more ... monocrotaline multiple interactions EXP 6480464 [Monocrotaline co-treated with LGALS3 protein] inhibits the reaction [[Monocrotaline co-treated with TGFB1] results in decreased expression of MMP9 protein] more ... CTD PMID:27870162 more ... morin multiple interactions EXP 6480464 morin inhibits the reaction [Diethylnitrosamine results in increased expression of MMP9 protein] CTD PMID:19539802 morin decreases expression ISO RGD:731911 6480464 morin results in decreased expression of MMP9 mRNA CTD PMID:16304905 morphine multiple interactions ISO RGD:731911 6480464 [7-nitroindazole results in decreased activity of NOS1 protein] inhibits the reaction [[Morphine co-treated with Naloxone] results in increased activity of MMP9 protein] more ... CTD PMID:20519536 morphine increases activity ISO RGD:731911 6480464 Morphine results in increased activity of MMP9 protein CTD PMID:20519536 morusin multiple interactions ISO RGD:1348437 6480464 morusin results in decreased expression of and results in decreased activity of MMP9 protein CTD PMID:25476160 moxifloxacin decreases secretion ISO RGD:1348437 6480464 Moxifloxacin results in decreased secretion of MMP9 protein CTD PMID:24890593 myricetin multiple interactions ISO RGD:1348437 6480464 myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] CTD PMID:19804834 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO RGD:1348437 6480464 N more ... CTD PMID:17015178 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO RGD:1348437 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA] CTD PMID:24929186 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [T-2 Toxin results in increased expression of MMP9 mRNA] CTD PMID:29079362 N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide multiple interactions ISO RGD:1348437 6480464 N-(3, 5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide inhibits the reaction [TNF results in increased expression of MMP9 mRNA] CTD PMID:17560598 N-acetyl-L-cysteine multiple interactions ISO RGD:1348437 6480464 Acetylcysteine inhibits the reaction [4-aminophenylmercuriacetate results in increased activity of MMP9 protein] more ... CTD PMID:15962302 more ... N-acetyl-L-cysteine decreases activity ISO RGD:1348437 6480464 Acetylcysteine results in decreased activity of MMP9 protein CTD PMID:18930813 N-acetyl-L-cysteine decreases activity EXP 6480464 Acetylcysteine results in decreased activity of MMP9 protein CTD PMID:15451797 N-acetyl-L-cysteine multiple interactions EXP 6480464 [Ethanol co-treated with Dietary Fats co-treated with Acetylcysteine] results in increased expression of MMP9 mRNA more ... CTD PMID:16213474 more ... N-acetyl-L-cysteine multiple interactions ISO RGD:731911 6480464 Acetylcysteine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of MMP9 mRNA], Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] CTD PMID:15557194 , PMID:19962414 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1348437 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[IL1A co-treated with PDGFB] results in increased secretion of MMP9 protein] more ... CTD PMID:15728660 more ... N-methyl-4-phenylpyridinium increases expression ISO RGD:731911 6480464 1-Methyl-4-phenylpyridinium results in increased expression of MMP9 mRNA CTD PMID:19962414 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:731911 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of MMP9 mRNA], Acetylcysteine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of MMP9 mRNA] CTD PMID:19962414 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions EXP 6480464 Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP9 protein] more ... CTD PMID:20434464 N-methyl-N'-nitro-N-nitrosoguanidine increases expression EXP 6480464 Methylnitronitrosoguanidine results in increased expression of MMP9 mRNA CTD PMID:20434464 N-nitrosodiethylamine multiple interactions ISO RGD:731911 6480464 CCL3 protein affects the reaction [Diethylnitrosamine results in increased expression of MMP9 mRNA] more ... CTD PMID:16284949 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of MMP9 protein CTD PMID:19539802 N-nitrosodiethylamine increases activity EXP 6480464 Diethylnitrosamine results in increased activity of MMP9 protein CTD PMID:19052882 N-nitrosodiethylamine multiple interactions EXP 6480464 2-aminofluorene promotes the reaction [Diethylnitrosamine results in increased activity of MMP9 protein] more ... CTD PMID:19052882 more ... N-nitrosodiethylamine increases expression ISO RGD:731911 6480464 Diethylnitrosamine results in increased expression of MMP9 mRNA, Diethylnitrosamine results in increased expression of MMP9 protein CTD PMID:16284949 N-nitrosodimethylamine increases activity EXP 6480464 Dimethylnitrosamine results in increased activity of MMP9 protein CTD PMID:15161499 N-tosyl-L-phenylalanyl chloromethyl ketone decreases activity ISO RGD:1348437 6480464 Tosylphenylalanyl Chloromethyl Ketone results in decreased activity of MMP9 protein CTD PMID:22033475 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 Ranitidine inhibits the reaction [Ethanol results in increased secretion of and results in increased activity of MMP9 protein], Ranitidine inhibits the reaction [Indomethacin results in increased expression of MMP9 protein] CTD PMID:17603938 , PMID:29523851 naloxone multiple interactions ISO RGD:731911 6480464 [7-nitroindazole results in decreased activity of NOS1 protein] inhibits the reaction [[Morphine co-treated with Naloxone] results in increased activity of MMP9 protein], [Morphine co-treated with Naloxone] results in increased activity of MMP9 protein CTD PMID:20519536 Nandrolone decanoate multiple interactions EXP 6480464 Taurine inhibits the reaction [nandrolone decanoate results in increased expression of MMP9 mRNA] CTD PMID:25542992 Nandrolone decanoate increases expression EXP 6480464 nandrolone decanoate results in increased expression of MMP9 mRNA CTD PMID:25542992 naphthalene increases expression ISO RGD:731911 6480464 naphthalene results in increased expression of MMP9 mRNA CTD PMID:18978301 naringin multiple interactions ISO RGD:731911 6480464 naringin inhibits the reaction [Paraquat results in increased expression of MMP9 mRNA], naringin inhibits the reaction [Paraquat results in increased expression of MMP9 protein] CTD PMID:23603004 naringin multiple interactions EXP 6480464 naringin inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein] more ... CTD PMID:19810018 , PMID:22985397 naringin multiple interactions ISO RGD:1348437 6480464 naringin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA], naringin results in decreased expression of and results in decreased activity of MMP9 protein CTD PMID:25866363 , PMID:26721195 nickel atom multiple interactions ISO RGD:1348437 6480464 tanespimycin affects the reaction [Nickel results in increased activity of MMP9 protein], tanespimycin inhibits the reaction [Nickel results in increased expression of MMP9 mRNA] CTD PMID:21401309 nickel atom increases expression ISO RGD:1348437 6480464 Nickel results in increased expression of MMP9 mRNA, Nickel results in increased expression of MMP9 protein CTD PMID:21401309 more ... nickel atom multiple interactions ISO RGD:731911 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA, TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA] CTD PMID:23503329 nickel atom increases activity ISO RGD:1348437 6480464 Nickel results in increased activity of MMP9 protein CTD PMID:21401309 nickel dichloride increases expression ISO RGD:1348437 6480464 nickel chloride results in increased expression of MMP9 protein CTD PMID:21473897 nickel dichloride multiple interactions ISO RGD:1348437 6480464 chrysin inhibits the reaction [nickel chloride results in increased expression of and results in increased activity of MMP9 protein] more ... CTD PMID:30016632 nickel dichloride increases activity ISO RGD:1348437 6480464 nickel chloride results in increased activity of MMP9 protein CTD PMID:26962057 nickel sulfate increases expression ISO RGD:1348437 6480464 nickel sulfate results in increased expression of MMP9 mRNA CTD PMID:18651567 nickel sulfate multiple interactions ISO RGD:1348437 6480464 nickel sulfate results in increased expression of and results in increased secretion of MMP9 protein CTD PMID:15020194 Niclosamide decreases expression ISO RGD:1348437 6480464 Niclosamide results in decreased expression of MMP9 protein CTD PMID:29480568 Niclosamide multiple interactions ISO RGD:731911 6480464 Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of MMP9 mRNA] CTD PMID:28824321 nicotinamide multiple interactions ISO RGD:1348437 6480464 Niacinamide inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]], resveratrol inhibits the reaction [Niacinamide results in increased expression of MMP9 protein] CTD PMID:24145604 , PMID:24962570 nicotinamide increases expression ISO RGD:1348437 6480464 Niacinamide results in increased expression of MMP9 protein CTD PMID:24962570 nicotine increases expression ISO RGD:1348437 6480464 Nicotine results in increased expression of MMP9 mRNA, Nicotine results in increased expression of MMP9 protein CTD PMID:14569062 , PMID:20061081 nicotine multiple interactions ISO RGD:1348437 6480464 MK-886 inhibits the reaction [Nicotine results in increased expression of MMP9 mRNA] CTD PMID:20061081 nicotine decreases expression ISO RGD:731911 6480464 Nicotine results in decreased expression of MMP9 protein CTD PMID:20448088 nifedipine multiple interactions ISO RGD:1348437 6480464 Nifedipine results in decreased expression of and results in decreased activity of MMP9 protein CTD PMID:18204791 nimesulide decreases expression ISO RGD:1348437 6480464 nimesulide results in decreased expression of MMP9 mRNA, nimesulide results in decreased expression of MMP9 protein CTD PMID:21176579 nitric oxide increases expression ISO RGD:731911 6480464 Nitric Oxide results in increased expression of MMP9 mRNA CTD PMID:20197249 nitrobenzenes decreases expression EXP 6480464 Nitrobenzenes analog results in decreased expression of MMP9 mRNA CTD PMID:19784758 nitroglycerin increases activity ISO RGD:1348437 6480464 Nitroglycerin results in increased activity of MMP9 protein CTD PMID:12084592 nitroglycerin increases expression ISO RGD:1348437 6480464 Nitroglycerin results in increased expression of MMP9 mRNA CTD PMID:12084592 Nonidet P-40 decreases expression ISO RGD:1348437 6480464 Nonidet P-40 results in decreased expression of MMP9 mRNA CTD PMID:26552463 Nonylphenol multiple interactions ISO RGD:1348437 6480464 fulvestrant inhibits the reaction [nonylphenol results in increased expression of MMP9 protein] CTD PMID:25690688 Nonylphenol increases expression ISO RGD:1348437 6480464 nonylphenol results in increased expression of MMP9 protein CTD PMID:25690688 NS-398 multiple interactions ISO RGD:1348437 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [anandamide results in increased expression of MMP9 mRNA] more ... CTD PMID:11981761 more ... O-(chloroacetylcarbamoyl)fumagillol multiple interactions ISO RGD:1348437 6480464 [O-(chloroacetylcarbamoyl)fumagillol co-treated with docetaxel] results in decreased expression of MMP9 protein CTD PMID:12576464 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of MMP9 protein CTD PMID:16622519 ochratoxin A increases expression ISO RGD:731911 6480464 ochratoxin A results in increased expression of MMP9 mRNA, ochratoxin A results in increased expression of MMP9 protein CTD PMID:28710020 ochratoxin A multiple interactions ISO RGD:731911 6480464 NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of MMP9 protein] CTD PMID:28710020 ochratoxin A multiple interactions EXP 6480464 Ethanol affects the reaction [ochratoxin A results in increased expression of MMP9 protein] CTD PMID:16622519 oleuropein multiple interactions ISO RGD:1348437 6480464 oleuropein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA], oleuropein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] CTD PMID:22595400 oridonin decreases expression ISO RGD:1348437 6480464 oridonin analog results in decreased expression of MMP9 protein CTD PMID:31594861 oroxylin A decreases expression ISO RGD:1348437 6480464 5 more ... CTD PMID:22245252 oroxylin A multiple interactions ISO RGD:1348437 6480464 5, 7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] CTD PMID:22245252 osthole multiple interactions ISO RGD:1348437 6480464 osthol inhibits the reaction [RELA protein binds to MMP9 promoter], osthol results in decreased activity of and results in decreased expression of MMP9 protein CTD PMID:22503731 osthole decreases expression ISO RGD:1348437 6480464 osthol results in decreased expression of MMP9 mRNA CTD PMID:22503731 ouabain decreases expression ISO RGD:1348437 6480464 Ouabain results in decreased expression of MMP9 protein CTD PMID:28795476 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of MMP9 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of MMP9 mRNA CTD PMID:25729387 oxidopamine increases expression ISO RGD:1348437 6480464 Oxidopamine results in increased expression of MMP9 mRNA CTD PMID:19962414 oxidopamine multiple interactions ISO RGD:1348437 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxidopamine results in increased expression of MMP9 mRNA] more ... CTD PMID:19962414 oxytocin decreases response to substance EXP 6480464 MMP9 protein results in decreased susceptibility to Oxytocin CTD PMID:22496348 ozone increases expression ISO RGD:1348437 6480464 Ozone results in increased expression of MMP9 mRNA, Ozone results in increased expression of MMP9 protein CTD PMID:27206323 , PMID:28412860 ozone increases expression ISO RGD:731911 6480464 Ozone results in increased expression of MMP9 mRNA, Ozone results in increased expression of MMP9 protein CTD PMID:12763055 , PMID:18007984 ozone decreases response to substance ISO RGD:731911 6480464 MMP9 protein results in decreased susceptibility to Ozone CTD PMID:18007984 ozone increases activity ISO RGD:731911 6480464 Ozone results in increased activity of MMP9 protein CTD PMID:12763055 , PMID:18007984 ozone multiple interactions ISO RGD:731911 6480464 MMP9 gene mutant form promotes the reaction [Ozone results in increased activity of MMP2 protein] more ... CTD PMID:18007984 p-cresol multiple interactions ISO RGD:1348437 6480464 4-cresol results in increased expression of and results in increased activity of MMP9 protein more ... CTD PMID:30910523 paclitaxel multiple interactions ISO RGD:1348437 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of MMP9 mRNA, Curcumin inhibits the reaction [Paclitaxel results in increased expression of MMP9 protein] CTD PMID:16243823 , PMID:20705681 paracetamol affects expression ISO RGD:731911 6480464 Acetaminophen affects the expression of MMP9 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1348437 6480464 Acetaminophen results in decreased expression of MMP9 mRNA CTD PMID:26690555 paracetamol increases expression ISO RGD:731911 6480464 Acetaminophen results in increased expression of MMP9 mRNA, Acetaminophen results in increased expression of MMP9 protein CTD PMID:12392966 more ... paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MMP9 mRNA CTD PMID:19784758 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of MMP9 mRNA CTD PMID:19784758 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of MMP9 mRNA CTD PMID:19784758 paracetamol multiple interactions ISO RGD:731911 6480464 FLT1 protein affects the reaction [Acetaminophen results in increased expression of MMP9 mRNA] more ... CTD PMID:14550746 more ... paraquat increases expression ISO RGD:1348437 6480464 Paraquat results in increased expression of MMP9 mRNA CTD PMID:22230393 paraquat multiple interactions ISO RGD:1348437 6480464 [CCN2 protein co-treated with Paraquat] affects the expression of MMP9 mRNA CTD PMID:26129822 paraquat increases expression EXP 6480464 Paraquat results in increased expression of MMP9 mRNA, Paraquat results in increased expression of MMP9 protein CTD PMID:18630695 more ... paraquat multiple interactions EXP 6480464 Losartan inhibits the reaction [Paraquat results in increased expression of MMP9 mRNA] CTD PMID:25233898 paraquat increases expression ISO RGD:731911 6480464 Paraquat results in increased expression of MMP9 mRNA, Paraquat results in increased expression of MMP9 protein CTD PMID:17215068 more ... paraquat multiple interactions ISO RGD:731911 6480464 ADIPOQ protein inhibits the reaction [Paraquat results in increased expression of MMP9 protein] more ... CTD PMID:21765237 more ... parthenolide multiple interactions ISO RGD:1348437 6480464 parthenolide inhibits the reaction [RELA protein binds to MMP9 promoter] CTD PMID:20093109 perfluorooctane-1-sulfonic acid increases activity EXP 6480464 perfluorooctane sulfonic acid results in increased activity of MMP9 protein CTD PMID:28973641 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1348437 6480464 perfluorooctane sulfonic acid results in decreased expression of MMP9 mRNA CTD PMID:32219433 perfluorooctane-1-sulfonic acid increases expression ISO RGD:731911 6480464 perfluorooctane sulfonic acid results in increased expression of MMP9 protein CTD PMID:27818224 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:731911 6480464 ATF2 protein promotes the reaction [perfluorooctane sulfonic acid results in increased expression of MMP9 protein], SB 203580 inhibits the reaction [perfluorooctane sulfonic acid results in increased expression of MMP9 protein] CTD PMID:27818224 perfluorooctanoic acid multiple interactions ISO RGD:1348437 6480464 4-methyl-N1-(3-phenylpropyl)benzene-1 more ... CTD PMID:21075133 more ... perfluorooctanoic acid increases expression ISO RGD:1348437 6480464 perfluorooctanoic acid results in increased expression of MMP9 mRNA, perfluorooctanoic acid results in increased expression of MMP9 protein CTD PMID:24960061 , PMID:29753068 perindopril multiple interactions EXP 6480464 Perindopril inhibits the reaction [Carbon Tetrachloride results in increased activity of MMP9 protein] CTD PMID:16097048 phenanthrolines decreases activity EXP 6480464 Phenanthrolines results in decreased activity of MMP9 protein CTD PMID:14662518 phenethyl caffeate decreases expression ISO RGD:731911 6480464 caffeic acid phenethyl ester results in decreased expression of MMP9 protein CTD PMID:20433813 phenethyl caffeate decreases activity EXP 6480464 caffeic acid phenethyl ester results in decreased activity of MMP9 protein CTD PMID:20836997 phenethyl caffeate multiple interactions EXP 6480464 NGFR protein affects the susceptibility to [caffeic acid phenethyl ester results in decreased activity of MMP9 protein] CTD PMID:20836997 phenethyl isothiocyanate multiple interactions ISO RGD:1348437 6480464 phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] CTD PMID:23724058 phenylarsine oxide multiple interactions ISO RGD:1348437 6480464 oxophenylarsine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] CTD PMID:10569804 phenylephrine increases expression ISO RGD:1348437 6480464 Phenylephrine results in increased expression of MMP9 mRNA CTD PMID:16574429 PhIP multiple interactions ISO RGD:1348437 6480464 U 0126 inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of MMP9 protein] CTD PMID:22307971 PhIP increases secretion ISO RGD:1348437 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased secretion of MMP9 protein CTD PMID:20951759 PhIP increases expression ISO RGD:1348437 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of MMP9 protein CTD PMID:22307971 phorbol 12,13-dibutanoate increases activity ISO RGD:731911 6480464 Phorbol 12, 13-Dibutyrate results in increased activity of MMP9 protein CTD PMID:14593496 phorbol 12,13-dibutanoate multiple interactions ISO RGD:731911 6480464 Quercetin inhibits the reaction [Phorbol 12, 13-Dibutyrate results in increased activity of MMP9 protein] CTD PMID:14593496 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1348437 6480464 1 more ... CTD PMID:10455257 more ... phorbol 13-acetate 12-myristate increases expression ISO RGD:731911 6480464 Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein CTD PMID:9848099 phorbol 13-acetate 12-myristate increases expression ISO RGD:1348437 6480464 Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA, Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein CTD PMID:10569804 more ... phorbol 13-acetate 12-myristate increases activity ISO RGD:1348437 6480464 Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein CTD PMID:10455257 more ... phorbol 13-acetate 12-myristate increases secretion ISO RGD:1348437 6480464 Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein CTD PMID:12745093 more ... phorbol 13-acetate 12-myristate multiple interactions ISO RGD:731911 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MMP9 mRNA more ... CTD PMID:14515793 more ... phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein more ... CTD PMID:14700523 , PMID:16647178 phosgene multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [Phosgene results in increased expression of MMP9 mRNA], Dexamethasone inhibits the reaction [Phosgene results in increased expression of MMP9 protein] CTD PMID:21941784 phosgene increases expression EXP 6480464 Phosgene results in increased expression of MMP9 mRNA, Phosgene results in increased expression of MMP9 protein CTD PMID:21941784 pioglitazone multiple interactions ISO RGD:1348437 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]], pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] CTD PMID:17055343 pioglitazone decreases expression ISO RGD:1348437 6480464 Pioglitazone results in decreased expression of MMP9 mRNA CTD PMID:30031879 pioglitazone decreases secretion ISO RGD:1348437 6480464 pioglitazone results in decreased secretion of MMP9 protein CTD PMID:16860414 piperine decreases expression ISO RGD:1348437 6480464 piperine results in decreased expression of MMP9 protein CTD PMID:15531295 piperine multiple interactions ISO RGD:1348437 6480464 piperine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA], piperine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] CTD PMID:21354279 pipoxolan multiple interactions ISO RGD:1348437 6480464 pipoxolan results in decreased expression of and results in decreased activity of MMP9 protein CTD PMID:25899827 platycodin D decreases activity ISO RGD:1348437 6480464 platycodin D results in decreased activity of MMP9 protein CTD PMID:23867902 platycodin D decreases expression EXP 6480464 platycodin D results in decreased expression of MMP9 protein CTD PMID:29595072 platycodin D decreases expression ISO RGD:1348437 6480464 platycodin D results in decreased expression of MMP9 mRNA CTD PMID:23867902 pravastatin decreases activity EXP 6480464 Pravastatin results in decreased activity of MMP9 protein CTD PMID:16935385 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of MMP9 mRNA CTD PMID:16935385 prednisolone multiple interactions EXP 6480464 Prednisolone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of MMP9 protein] CTD PMID:22119283 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:731911 6480464 Pregnenolone Carbonitrile results in decreased expression of MMP9 mRNA CTD PMID:22698814 Pristimerin multiple interactions EXP 6480464 pristimerin inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA], pristimerin inhibits the reaction [Doxorubicin results in increased expression of MMP9 protein] CTD PMID:30588110 probucol multiple interactions ISO RGD:1348437 6480464 Probucol inhibits the reaction [TNF protein results in increased expression of MMP9 protein] CTD PMID:17964422 progesterone multiple interactions ISO RGD:1348437 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of MMP9 mRNA more ... CTD PMID:17404688 more ... progesterone increases expression ISO RGD:1348437 6480464 Progesterone results in increased expression of MMP9 mRNA CTD PMID:20226447 , PMID:26604029 progesterone increases expression EXP 6480464 Progesterone results in increased expression of MMP9 mRNA CTD PMID:21770760 progesterone multiple interactions ISO RGD:731911 6480464 Progesterone inhibits the reaction [Estradiol results in increased expression of MMP9 mRNA] CTD PMID:19416213 propranolol multiple interactions ISO RGD:1348437 6480464 DLL4 protein inhibits the reaction [Propranolol results in decreased expression of MMP9 protein] more ... CTD PMID:16574429 more ... propranolol decreases secretion ISO RGD:1348437 6480464 Propranolol results in decreased secretion of MMP9 protein CTD PMID:20424515 propranolol decreases expression ISO RGD:1348437 6480464 Propranolol results in decreased expression of MMP9 more ... CTD PMID:20424515 more ... prostaglandin E2 multiple interactions ISO RGD:1348437 6480464 15-deoxyprostaglandin J2 inhibits the reaction [Dinoprostone results in increased expression of MMP9 mRNA] more ... CTD PMID:19880272 , PMID:25094029 prostaglandin E2 increases secretion ISO RGD:1348437 6480464 Dinoprostone results in increased secretion of MMP9 protein CTD PMID:19880272 prostaglandin E2 increases expression ISO RGD:1348437 6480464 Dinoprostone results in increased expression of MMP9 mRNA, Dinoprostone results in increased expression of MMP9 protein CTD PMID:16330497 , PMID:19880272 prostaglandin F2alpha multiple interactions ISO RGD:1348437 6480464 Dinoprost results in increased expression of and results in increased activity of MMP9 protein CTD PMID:11719597 protein kinase inhibitor multiple interactions ISO RGD:1348437 6480464 [Protein Kinase Inhibitors results in decreased activity of MAPK14 protein] inhibits the reaction [taiwanin E results in decreased expression of MMP9 mRNA], [Protein Kinase Inhibitors results in decreased activity of MAPK14 protein] inhibits the reaction [taiwanin E results in decreased expression of MMP9 protein] CTD PMID:27807932 Ptaquiloside multiple interactions ISO RGD:731911 6480464 [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of MMP9 mRNA CTD PMID:23274088 Ptaquiloside decreases expression ISO RGD:731911 6480464 ptaquiloside results in decreased expression of MMP9 mRNA CTD PMID:23274088 pterostilbene decreases expression ISO RGD:1348437 6480464 pterostilbene results in decreased expression of MMP9 mRNA CTD PMID:20152895 pterostilbene decreases activity ISO RGD:1348437 6480464 pterostilbene results in decreased activity of MMP9 protein CTD PMID:19617202 pterostilbene multiple interactions ISO RGD:731911 6480464 pterostilbene inhibits the reaction [MMP7 protein results in increased activity of MMP9 protein] CTD PMID:20681671 pterostilbene multiple interactions ISO RGD:1348437 6480464 pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein], pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] CTD PMID:19447859 pyrrolidine dithiocarbamate decreases activity ISO RGD:1348437 6480464 pyrrolidine dithiocarbamic acid results in decreased activity of MMP9 protein CTD PMID:22033475 pyrrolidine dithiocarbamate decreases expression ISO RGD:1348437 6480464 pyrrolidine dithiocarbamic acid results in decreased expression of MMP9 mRNA CTD PMID:23566884 pyrrolidine dithiocarbamate multiple interactions ISO RGD:1348437 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [EGF protein results in increased activity of MMP9 protein], pyrrolidine dithiocarbamic acid inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA] CTD PMID:16340751 quercetin decreases activity ISO RGD:731911 6480464 Quercetin results in decreased activity of MMP9 protein CTD PMID:14593496 , PMID:24275163 quercetin multiple interactions EXP 6480464 [Quercetin co-treated with polylactic acid-polyglycolic acid copolymer] inhibits the reaction [Ethanol results in increased expression of and results in increased activity of MMP9 protein] more ... CTD PMID:14700523 more ... quercetin multiple interactions ISO RGD:731911 6480464 Doxorubicin inhibits the reaction [Quercetin results in decreased activity of MMP9 protein] more ... CTD PMID:14593496 more ... quercetin decreases activity ISO RGD:1348437 6480464 Quercetin results in decreased activity of MMP9 protein CTD PMID:22871832 quercetin increases expression ISO RGD:1348437 6480464 Quercetin results in increased expression of MMP9 protein CTD PMID:10556937 quercetin decreases expression ISO RGD:731911 6480464 Quercetin results in decreased expression of MMP9 mRNA CTD PMID:16304905 , PMID:24275163 quercetin decreases expression ISO RGD:1348437 6480464 Quercetin results in decreased expression of MMP9 mRNA, Quercetin results in decreased expression of MMP9 protein CTD PMID:22871832 more ... quercetin decreases secretion ISO RGD:1348437 6480464 Quercetin results in decreased secretion of MMP9 protein CTD PMID:15135307 quercetin multiple interactions ISO RGD:1348437 6480464 Quercetin analog inhibits the reaction [24-hydroxycholesterol results in increased expression of MMP9 mRNA] more ... CTD PMID:12589822 more ... quercetin 3-O-beta-D-glucofuranoside multiple interactions ISO RGD:1348437 6480464 isoquercitrin results in decreased expression of and results in decreased activity of MMP9 protein CTD PMID:18715546 quercetin 3-O-beta-D-glucopyranoside multiple interactions ISO RGD:1348437 6480464 isoquercitrin results in decreased expression of and results in decreased activity of MMP9 protein CTD PMID:18715546 quinpirole decreases secretion ISO RGD:1348437 6480464 Quinpirole results in decreased secretion of MMP9 protein CTD PMID:27920206 raloxifene decreases expression ISO RGD:1348437 6480464 Raloxifene Hydrochloride results in decreased expression of MMP9 mRNA CTD PMID:17582780 raloxifene multiple interactions EXP 6480464 [9 more ... CTD PMID:31332895 raloxifene increases expression ISO RGD:731911 6480464 Raloxifene Hydrochloride results in increased expression of MMP9 mRNA CTD PMID:22841776 raloxifene decreases activity ISO RGD:1348437 6480464 Raloxifene Hydrochloride results in decreased activity of MMP9 protein CTD PMID:17582780 ranitidine multiple interactions EXP 6480464 Ranitidine inhibits the reaction [Ethanol results in increased secretion of and results in increased activity of MMP9 protein], Ranitidine inhibits the reaction [Indomethacin results in increased expression of MMP9 protein] CTD PMID:17603938 , PMID:29523851 razoxane multiple interactions EXP 6480464 Razoxane inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA] CTD PMID:16213474 reactive oxygen species multiple interactions ISO RGD:1348437 6480464 Reactive Oxygen Species affects the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] CTD PMID:19804834 reactive oxygen species multiple interactions ISO RGD:731911 6480464 Reactive Oxygen Species affects the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] CTD PMID:15557194 rebaudioside A increases expression ISO RGD:1348437 6480464 rebaudioside A results in increased expression of MMP9 mRNA CTD PMID:31655124 regorafenib decreases expression ISO RGD:1348437 6480464 regorafenib results in decreased expression of MMP9 protein CTD PMID:30801954 resveratrol multiple interactions ISO RGD:731911 6480464 [resveratrol co-treated with Glucose] results in decreased activity of MMP9 protein more ... CTD PMID:14515793 more ... resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of MMP9 mRNA, resveratrol results in decreased expression of MMP9 protein CTD PMID:19228061 more ... resveratrol decreases expression ISO RGD:1348437 6480464 Resveratrol results in decreased expression of MMP9 more ... CTD PMID:14627504 more ... resveratrol decreases secretion ISO RGD:1348437 6480464 resveratrol results in decreased secretion of MMP9 protein CTD PMID:18674879 resveratrol affects expression ISO RGD:1348437 6480464 resveratrol affects the expression of MMP9 protein CTD PMID:17007354 resveratrol decreases activity ISO RGD:1348437 6480464 resveratrol results in decreased activity of MMP9 protein CTD PMID:15688415 , PMID:17935668 resveratrol decreases expression ISO RGD:731911 6480464 resveratrol results in decreased expression of MMP9 mRNA CTD PMID:16304905 , PMID:16321402 resveratrol increases secretion ISO RGD:1348437 6480464 resveratrol results in increased secretion of MMP9 protein CTD PMID:22314268 resveratrol multiple interactions ISO RGD:1348437 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Resveratrol results in increased expression of and results in increased activity of MMP9 protein] more ... CTD PMID:14627504 more ... resveratrol decreases activity EXP 6480464 resveratrol results in decreased activity of MMP9 protein CTD PMID:21962734 resveratrol multiple interactions EXP 6480464 [Dimethyl Sulfoxide co-treated with Resveratrol] inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein] more ... CTD PMID:12208745 more ... riboflavin increases activity ISO RGD:731911 6480464 Riboflavin analog results in increased activity of MMP9 protein, Riboflavin results in increased activity of MMP9 protein CTD PMID:20688149 rosmarinic acid decreases expression EXP 6480464 rosmarinic acid results in decreased expression of MMP9 mRNA, rosmarinic acid results in decreased expression of MMP9 protein CTD PMID:28789951 rotenone multiple interactions ISO RGD:731911 6480464 Rotenone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of MMP9 protein], Rotenone inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] CTD PMID:15557194 , PMID:30857887 rottlerin multiple interactions ISO RGD:731911 6480464 rottlerin inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] CTD PMID:15557194 roxarsone increases expression ISO RGD:1348437 6480464 Roxarsone results in increased expression of MMP9 mRNA, Roxarsone results in increased expression of MMP9 protein CTD PMID:22952646 rutin decreases expression ISO RGD:731911 6480464 Rutin results in decreased expression of MMP9 mRNA CTD PMID:16304905 rutin multiple interactions ISO RGD:731911 6480464 Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA], Rutin inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein] CTD PMID:29743444 Salinomycin decreases secretion ISO RGD:1348437 6480464 salinomycin results in decreased secretion of MMP9 protein CTD PMID:28395993 sanguinarine decreases expression ISO RGD:1348437 6480464 sanguinarine results in decreased expression of MMP9 mRNA, sanguinarine results in decreased expression of MMP9 protein CTD PMID:19063874 saxagliptin multiple interactions EXP 6480464 saxagliptin inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA], saxagliptin inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein] CTD PMID:31629700 SB 203580 decreases expression ISO RGD:731911 6480464 SB 203580 results in decreased expression of MMP9 mRNA CTD PMID:15657063 SB 203580 decreases expression ISO RGD:1348437 6480464 SB 203580 results in decreased expression of MMP9 mRNA, SB 203580 results in decreased expression of MMP9 protein CTD PMID:27829220 , PMID:30801954 SB 203580 multiple interactions ISO RGD:731911 6480464 SB 203580 inhibits the reaction [Leukotriene B4 results in increased expression of MMP9 protein] more ... CTD PMID:19837106 , PMID:27818224 SB 203580 decreases activity ISO RGD:1348437 6480464 SB 203580 results in decreased activity of MMP9 protein CTD PMID:22033475 SB 203580 multiple interactions ISO RGD:1348437 6480464 [kahweol acetate co-treated with SB 203580] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein] more ... CTD PMID:15728660 more ... SB 203580 decreases activity ISO RGD:731911 6480464 SB 203580 results in decreased activity of MMP9 protein CTD PMID:15657063 SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [Doxorubicin results in increased activity of MMP9 protein] more ... CTD PMID:12493575 more ... selenium atom decreases expression ISO RGD:1348437 6480464 Selenium results in decreased expression of MMP9 mRNA CTD PMID:17390030 selumetinib decreases activity ISO RGD:1348437 6480464 AZD 6244 results in decreased activity of MMP9 protein CTD PMID:31790661 serpentine asbestos increases secretion ISO RGD:1348437 6480464 Asbestos, Serpentine results in increased secretion of MMP9 protein CTD PMID:26685284 serpentine asbestos increases expression ISO RGD:731911 6480464 Asbestos, Serpentine results in increased expression of MMP9, Asbestos, Serpentine results in increased expression of MMP9 mRNA CTD PMID:18039278 , PMID:19105532 serpentine asbestos increases activity ISO RGD:731911 6480464 Asbestos, Serpentine results in increased activity of MMP9 protein CTD PMID:16571779 sevoflurane multiple interactions EXP 6480464 MIR34A mRNA promotes the reaction [Sevoflurane inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]] more ... CTD PMID:32147387 silibinin decreases activity ISO RGD:1348437 6480464 Silybin results in decreased activity of MMP9 protein CTD PMID:21969006 silibinin decreases expression ISO RGD:1348437 6480464 Silybin results in decreased expression of MMP9 mRNA CTD PMID:21969006 silibinin multiple interactions ISO RGD:1348437 6480464 [Arsenic Trioxide co-treated with Silybin] results in decreased expression of MMP9 mRNA, [Silybin co-treated with Arsenic Trioxide] results in decreased activity of MMP9 protein CTD PMID:21969006 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of MMP9 mRNA CTD PMID:21602193 silicon dioxide multiple interactions ISO RGD:731911 6480464 Vitamin D inhibits the reaction [Silicon Dioxide results in decreased expression of MMP9 protein] CTD PMID:30698894 silicon dioxide decreases expression ISO RGD:731911 6480464 Silicon Dioxide results in decreased expression of MMP9 protein CTD PMID:30698894 silicon dioxide increases expression ISO RGD:1348437 6480464 Silicon Dioxide results in increased expression of MMP9 mRNA CTD PMID:22931364 silicon dioxide multiple interactions ISO RGD:1348437 6480464 fisetin inhibits the reaction [Silicon Dioxide results in increased expression of MMP9 mRNA] CTD PMID:22931364 simazine decreases expression ISO RGD:731911 6480464 Simazine results in decreased expression of MMP9 mRNA CTD PMID:22984576 , PMID:27431321 simvastatin multiple interactions ISO RGD:1348437 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased expression of MMP9 mRNA]] more ... CTD PMID:15537504 more ... simvastatin increases activity EXP 6480464 Simvastatin results in increased activity of MMP9 protein CTD PMID:23831763 simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of MMP9 mRNA, Simvastatin results in decreased expression of MMP9 protein CTD PMID:16414398 , PMID:18309148 simvastatin decreases expression ISO RGD:1348437 6480464 Simvastatin results in decreased expression of MMP9 protein CTD PMID:17038636 more ... simvastatin decreases activity EXP 6480464 Simvastatin results in decreased activity of MMP9 protein CTD PMID:18569431 simvastatin decreases activity ISO RGD:731911 6480464 Simvastatin results in decreased activity of MMP9 protein CTD PMID:17169357 simvastatin multiple interactions EXP 6480464 farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]] more ... CTD PMID:16002570 more ... simvastatin multiple interactions ISO RGD:731911 6480464 Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of MMP9 mRNA], Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of MMP9 protein] CTD PMID:20835264 simvastatin decreases activity ISO RGD:1348437 6480464 Simvastatin results in decreased activity of MMP9 protein CTD PMID:15107580 simvastatin increases activity ISO RGD:1348437 6480464 Simvastatin results in increased activity of MMP9 protein CTD PMID:15210533 sirolimus decreases expression EXP 6480464 Sirolimus results in decreased expression of MMP9 mRNA CTD PMID:21865292 sodium arsenite multiple interactions ISO RGD:1348437 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein] more ... CTD PMID:15504454 more ... sodium arsenite increases activity EXP 6480464 sodium arsenite results in increased activity of MMP9 protein CTD PMID:21167264 , PMID:23137061 sodium arsenite increases expression ISO RGD:731911 6480464 sodium arsenite results in increased expression of MMP9 mRNA CTD PMID:16014739 , PMID:21134390 sodium arsenite increases secretion ISO RGD:1348437 6480464 sodium arsenite results in increased secretion of MMP9 protein CTD PMID:15504454 more ... sodium arsenite increases expression ISO RGD:1348437 6480464 sodium arsenite results in increased expression of MMP9 mRNA, sodium arsenite results in increased expression of MMP9 protein CTD PMID:21167264 sodium arsenite increases activity ISO RGD:1348437 6480464 sodium arsenite results in increased activity of MMP9 protein CTD PMID:21167264 sodium arsenite multiple interactions EXP 6480464 Gefitinib inhibits the reaction [HBEGF protein inhibits the reaction [sodium arsenite results in increased expression of and results in increased secretion of and results in increased activity of MMP9 protein]] more ... CTD PMID:19933942 , PMID:29228391 sodium arsenite increases secretion EXP 6480464 sodium arsenite results in increased secretion of MMP9 protein CTD PMID:19933942 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of MMP9 protein CTD PMID:21167264 , PMID:29228391 sodium dichromate decreases expression ISO RGD:1348437 6480464 sodium bichromate results in decreased expression of MMP9 mRNA CTD PMID:17685462 solasodine decreases expression ISO RGD:1348437 6480464 solasodine results in decreased expression of MMP9 mRNA CTD PMID:28283413 Soman increases expression EXP 6480464 Soman results in increased expression of MMP9 mRNA CTD PMID:19281266 sphingosine 1-phosphate multiple interactions ISO RGD:1348437 6480464 Fingolimod Hydrochloride inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 mRNA] more ... CTD PMID:25980589 , PMID:26518876 sphingosine 1-phosphate increases expression ISO RGD:1348437 6480464 sphingosine 1-phosphate results in increased expression of MMP9 mRNA, sphingosine 1-phosphate results in increased expression of MMP9 protein CTD PMID:25980589 , PMID:26518876 staurosporine multiple interactions ISO RGD:1348437 6480464 Staurosporine inhibits the reaction [Homocysteine results in increased activity of MMP9 protein], Staurosporine inhibits the reaction [Homocysteine results in increased expression of MMP9 protein] CTD PMID:16251475 steviol increases expression ISO RGD:1348437 6480464 steviol results in increased expression of MMP9 mRNA CTD PMID:31655124 stevioside increases expression ISO RGD:1348437 6480464 stevioside results in increased expression of MMP9 mRNA CTD PMID:31655124 streptozocin increases activity EXP 6480464 Streptozocin results in increased activity of MMP9 protein CTD PMID:25246140 streptozocin multiple interactions ISO RGD:731911 6480464 [Dietary Fats co-treated with Streptozocin] results in increased expression of MMP9 mRNA more ... CTD PMID:28478229 , PMID:29988851 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of MMP9 mRNA, Streptozocin results in increased expression of MMP9 protein CTD PMID:19236438 more ... streptozocin increases expression ISO RGD:731911 6480464 Streptozocin results in increased expression of MMP9 mRNA CTD PMID:20446767 , PMID:28478229 streptozocin multiple interactions ISO RGD:1348437 6480464 PRDX4 protein inhibits the reaction [Streptozocin results in increased expression of MMP9 mRNA] CTD PMID:20446767 streptozocin multiple interactions EXP 6480464 [Streptozocin co-treated with Tobacco Smoke Pollution] results in increased expression of MMP9 protein more ... CTD PMID:19236438 more ... succimer multiple interactions ISO RGD:731911 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MMP9 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MMP9 mRNA CTD PMID:21641980 , PMID:26378955 succimer multiple interactions ISO RGD:1348437 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MMP9 mRNA CTD PMID:26378955 sulfasalazine multiple interactions ISO RGD:1348437 6480464 Sulfasalazine inhibits the reaction [HGF protein results in increased expression of MMP9 mRNA] more ... CTD PMID:12745093 sulfasalazine multiple interactions EXP 6480464 Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of MMP9 protein] CTD PMID:22119283 sunitinib multiple interactions EXP 6480464 Carnitine inhibits the reaction [sunitinib results in decreased expression of MMP9 mRNA], SN50 peptide inhibits the reaction [sunitinib results in decreased expression of MMP9 mRNA] CTD PMID:26581635 sunitinib decreases expression EXP 6480464 sunitinib results in decreased expression of MMP9 mRNA CTD PMID:26581635 T-2 Toxin multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [T-2 Toxin results in increased expression of MMP9 mRNA] more ... CTD PMID:29079362 T-2 Toxin increases expression ISO RGD:731911 6480464 T-2 Toxin results in increased expression of MMP9 mRNA CTD PMID:21112371 , PMID:22800716 T-2 Toxin multiple interactions ISO RGD:731911 6480464 T-2 Toxin results in increased expression of and results in increased activity of MMP9 protein CTD PMID:22960706 T-2 Toxin increases expression EXP 6480464 T-2 Toxin results in increased expression of MMP9 mRNA CTD PMID:29079362 T-2 Toxin increases activity ISO RGD:731911 6480464 T-2 Toxin results in increased activity of MMP9 protein CTD PMID:21112371 T-2 Toxin affects expression ISO RGD:731911 6480464 T-2 Toxin affects the expression of MMP9 mRNA CTD PMID:22960706 tamoxifen affects expression ISO RGD:1348437 6480464 Tamoxifen affects the expression of MMP9 mRNA CTD PMID:14699072 tamoxifen decreases expression ISO RGD:1348437 6480464 Tamoxifen results in decreased expression of MMP9 mRNA CTD PMID:30153467 tamoxifen increases expression ISO RGD:731911 6480464 Tamoxifen results in increased expression of MMP9 mRNA CTD PMID:22841776 tamoxifen increases activity ISO RGD:731911 6480464 Tamoxifen results in increased activity of MMP9 protein CTD PMID:19279558 tamoxifen decreases activity ISO RGD:731911 6480464 Tamoxifen results in decreased activity of MMP9 protein CTD PMID:19393235 tamoxifen decreases activity EXP 6480464 Tamoxifen results in decreased activity of MMP9 protein CTD PMID:15696052 tamoxifen decreases expression ISO RGD:731911 6480464 Tamoxifen results in decreased expression of MMP9 mRNA CTD PMID:19393235 tamoxifen affects expression ISO RGD:731911 6480464 Tamoxifen affects the expression of MMP9 mRNA CTD PMID:17555576 tanespimycin multiple interactions ISO RGD:1348437 6480464 tanespimycin affects the reaction [Nickel results in increased activity of MMP9 protein], tanespimycin inhibits the reaction [Nickel results in increased expression of MMP9 mRNA] CTD PMID:21401309 Tanshinone I multiple interactions ISO RGD:1348437 6480464 tanshinone inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA] CTD PMID:24929186 taurine multiple interactions EXP 6480464 Taurine inhibits the reaction [nandrolone decanoate results in increased expression of MMP9 mRNA] CTD PMID:25542992 taurocholic acid multiple interactions ISO RGD:1348437 6480464 JTE 013 inhibits the reaction [Taurocholic Acid results in increased expression of MMP9 mRNA], JTE 013 inhibits the reaction [Taurocholic Acid results in increased expression of MMP9 protein] CTD PMID:26518876 taurocholic acid increases expression ISO RGD:1348437 6480464 Taurocholic Acid results in increased expression of MMP9 mRNA, Taurocholic Acid results in increased expression of MMP9 protein CTD PMID:26518876 tebuconazole decreases expression ISO RGD:1348437 6480464 tebuconazole results in decreased expression of MMP9 mRNA CTD PMID:26852204 temozolomide multiple interactions ISO RGD:1348437 6480464 resveratrol inhibits the reaction [temozolomide results in decreased expression of MMP9 protein] CTD PMID:22530672 temozolomide decreases expression ISO RGD:1348437 6480464 temozolomide results in decreased expression of MMP9 protein CTD PMID:22530672 tephrosin multiple interactions ISO RGD:1348437 6480464 tephrosin inhibits the reaction [TNF protein results in increased expression of MMP9 protein] CTD PMID:18841906 terbinafine decreases expression ISO RGD:1348437 6480464 terbinafine results in decreased expression of MMP9 mRNA CTD PMID:17172416 tetrachloromethane increases activity ISO RGD:731911 6480464 Carbon Tetrachloride results in increased activity of MMP9 protein CTD PMID:14999682 tetrachloromethane multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Interleukin 1 Receptor Antagonist Protein] results in increased expression of MMP9 mRNA more ... CTD PMID:16097048 more ... tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of MMP9 mRNA, Carbon Tetrachloride results in increased expression of MMP9 protein CTD PMID:16420518 more ... tetrachloromethane increases activity EXP 6480464 Carbon Tetrachloride results in increased activity of MMP9 protein CTD PMID:16097048 , PMID:22989100 tetrachloromethane increases expression ISO RGD:731911 24922203 CCl4 increases expression of mmp9 mRNA in Adipor2 KO mouse liver RGD tetrachloromethane decreases expression ISO RGD:731911 6480464 Carbon Tetrachloride results in decreased expression of MMP9 protein CTD PMID:19747501 , PMID:30056145 tetrachloromethane increases expression ISO RGD:731911 6480464 Carbon Tetrachloride results in increased expression of MMP9 mRNA, Carbon Tetrachloride results in increased expression of MMP9 protein CTD PMID:15056808 more ... tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of MMP9 mRNA, Carbon Tetrachloride results in decreased expression of MMP9 protein CTD PMID:17056239 more ... tetrachloromethane decreases activity EXP 6480464 Carbon Tetrachloride results in decreased activity of MMP9 protein CTD PMID:17156884 tetrachloromethane multiple interactions ISO RGD:731911 6480464 [Carbon Tetrachloride co-treated with 1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea] results in decreased expression of MMP9 mRNA more ... CTD PMID:14999682 more ... tetracyclines decreases activity EXP 6480464 Tetracyclines results in decreased activity of MMP9 protein CTD PMID:11172685 tetrahydrocurcumin multiple interactions ISO RGD:731911 6480464 tetrahydrocurcumin inhibits the reaction [Cadmium Chloride results in increased expression of MMP9 protein] CTD PMID:25502771 thalidomide decreases expression ISO RGD:1348437 6480464 Thalidomide results in decreased expression of MMP9 protein CTD PMID:15863203 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of MMP9 mRNA CTD PMID:19784758 thioacetamide multiple interactions ISO RGD:731911 6480464 ACE2 gene mutant form promotes the reaction [Thioacetamide results in increased activity of MMP9 protein], ACE2 gene mutant form promotes the reaction [Thioacetamide results in increased expression of MMP9 mRNA] CTD PMID:28845018 thioacetamide increases activity ISO RGD:731911 6480464 Thioacetamide results in increased activity of MMP9 protein CTD PMID:28845018 thioacetamide increases expression ISO RGD:731911 6480464 Thioacetamide results in increased expression of MMP9 mRNA CTD PMID:28845018 thioacetamide increases secretion EXP 6480464 Thioacetamide results in increased secretion of MMP9 protein CTD PMID:22899499 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MMP9 protein CTD PMID:15095483 thymol multiple interactions ISO RGD:731911 6480464 Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] more ... CTD PMID:30048646 thymol sulfate(1-) multiple interactions ISO RGD:731911 6480464 Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] more ... CTD PMID:30048646 thyroxine increases expression ISO RGD:731911 6480464 Thyroxine results in increased expression of MMP9 mRNA CTD PMID:23935926 Tiron multiple interactions ISO RGD:1348437 6480464 1 more ... CTD PMID:19371603 titanium atom increases expression ISO RGD:1348437 6480464 Titanium results in increased expression of MMP9 mRNA CTD PMID:14661256 titanium dioxide increases expression ISO RGD:1348437 6480464 titanium dioxide results in increased expression of MMP9 mRNA CTD PMID:19695317 titanium dioxide multiple interactions ISO RGD:731911 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MMP9 mRNA CTD PMID:29950665 titanium dioxide increases secretion ISO RGD:1348437 6480464 titanium dioxide results in increased secretion of MMP9 protein CTD PMID:23726862 titanium dioxide increases activity ISO RGD:1348437 6480464 titanium dioxide results in increased activity of MMP9 protein CTD PMID:23726862 titanium dioxide increases expression ISO RGD:731911 6480464 titanium dioxide results in increased expression of MMP9 mRNA CTD PMID:23557971 tofacitinib multiple interactions ISO RGD:731911 6480464 tofacitinib promotes the reaction [IL6 protein results in increased expression of MMP9 mRNA] CTD PMID:24285838 toluene 2,4-diisocyanate multiple interactions ISO RGD:731911 6480464 4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid inhibits the reaction [Toluene 2 more ... CTD PMID:15131573 , PMID:16516891 toluene 2,4-diisocyanate increases expression ISO RGD:731911 6480464 Toluene 2 more ... CTD PMID:12789230 more ... toluene 2,4-diisocyanate decreases expression ISO RGD:1348437 6480464 Toluene 2, 4-Diisocyanate results in decreased expression of MMP9 protein CTD PMID:12534559 toluene 2,4-diisocyanate increases activity ISO RGD:731911 6480464 Toluene 2, 4-Diisocyanate results in increased activity of MMP9 protein CTD PMID:11742282 tomatidine decreases expression ISO RGD:1348437 6480464 tomatidine results in decreased expression of MMP9 mRNA, tomatidine results in decreased expression of MMP9 protein CTD PMID:23566884 , PMID:31545954 tomatidine multiple interactions ISO RGD:1348437 6480464 tomatidine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] CTD PMID:31545954 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of MMP9 mRNA CTD PMID:25729387 trans-anethole decreases activity ISO RGD:1348437 6480464 anethole results in decreased activity of MMP9 protein CTD PMID:21212515 trans-anethole decreases expression ISO RGD:1348437 6480464 anethole results in decreased expression of MMP9 mRNA CTD PMID:21212515 trans-cinnamic acid multiple interactions ISO RGD:731911 6480464 cinnamic acid analog binds to and results in decreased activity of MMP9 protein CTD PMID:30048736 triadimefon decreases expression ISO RGD:1348437 6480464 triadimefon analog results in decreased expression of MMP9 mRNA CTD PMID:26238599 tributylstannane multiple interactions ISO RGD:731911 6480464 tributyltin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA] CTD PMID:22749964 tricetin multiple interactions ISO RGD:1348437 6480464 tricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein], tricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] CTD PMID:28731287 tricetin decreases expression ISO RGD:1348437 6480464 tricetin results in decreased expression of MMP9 mRNA, tricetin results in decreased expression of MMP9 protein CTD PMID:27860196 trichostatin A multiple interactions ISO RGD:1348437 6480464 AKT1 protein modified form inhibits the reaction [trichostatin A inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]] more ... CTD PMID:26509796 triclosan increases expression ISO RGD:1348437 6480464 Triclosan results in increased expression of MMP9 mRNA, Triclosan results in increased expression of MMP9 protein CTD PMID:26604029 , PMID:28844962 triclosan multiple interactions ISO RGD:1348437 6480464 3 more ... CTD PMID:26604029 , PMID:28844962 Triptolide multiple interactions ISO RGD:1348437 6480464 triptolide inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA], triptolide inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein] CTD PMID:25200491 Triptolide decreases expression ISO RGD:731911 6480464 triptolide results in decreased expression of MMP9 protein CTD PMID:26420756 troglitazone multiple interactions ISO RGD:1348437 6480464 troglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] CTD PMID:18155510 troglitazone decreases activity ISO RGD:1348437 6480464 troglitazone results in decreased activity of MMP9 protein CTD PMID:18155510 tungsten multiple interactions ISO RGD:731911 6480464 Tungsten results in increased expression of and results in increased secretion of MMP9 protein CTD PMID:25324207 tungsten decreases expression ISO RGD:731911 6480464 Tungsten results in decreased expression of MMP9 mRNA CTD PMID:30912803 Tungsten carbide multiple interactions ISO RGD:1348437 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of MMP9 mRNA CTD PMID:18078969 tyrphostin AG 1478 multiple interactions ISO RGD:1348437 6480464 RTKI cpd inhibits the reaction [Acrolein results in increased expression of MMP9 mRNA] more ... CTD PMID:15504454 more ... urethane multiple interactions ISO RGD:731911 6480464 [Urethane co-treated with Freund's Adjuvant] results in decreased expression of MMP9 mRNA CTD PMID:12400877 urethane decreases expression ISO RGD:731911 6480464 Urethane results in decreased expression of MMP9 mRNA CTD PMID:12400877 ursolic acid multiple interactions EXP 6480464 2 more ... CTD PMID:27274199 ursolic acid decreases expression ISO RGD:1348437 6480464 ursolic acid results in decreased expression of MMP9 mRNA CTD PMID:21539908 valproic acid affects expression ISO RGD:731911 6480464 Valproic Acid affects the expression of MMP9 mRNA CTD PMID:17963808 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of MMP9 mRNA CTD PMID:29427782 valproic acid multiple interactions EXP 6480464 Valproic Acid inhibits the reaction [Mechlorethamine results in increased expression of MMP9 mRNA] CTD PMID:28184907 valproic acid increases methylation ISO RGD:1348437 6480464 Valproic Acid results in increased methylation of MMP9 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1348437 6480464 Valproic Acid affects the expression of MMP9 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1348437 6480464 Valproic Acid results in increased expression of MMP9 mRNA CTD PMID:23179753 , PMID:23527032 valsartan multiple interactions EXP 6480464 [Valsartan co-treated with Fosinopril] results in decreased expression of MMP9 mRNA, [Valsartan co-treated with Fosinopril] results in decreased expression of MMP9 protein CTD PMID:21051829 valsartan decreases expression EXP 6480464 Valsartan results in decreased expression of MMP9 mRNA, Valsartan results in decreased expression of MMP9 protein CTD PMID:21051829 venlafaxine hydrochloride decreases expression EXP 6480464 Venlafaxine Hydrochloride results in decreased expression of MMP9 mRNA CTD PMID:25423262 vitamin D multiple interactions ISO RGD:731911 6480464 Vitamin D inhibits the reaction [Particulate Matter results in decreased expression of MMP9 protein], Vitamin D inhibits the reaction [Silicon Dioxide results in decreased expression of MMP9 protein] CTD PMID:30698894 vitamin D increases expression ISO RGD:731911 6480464 Vitamin D results in increased expression of MMP9 protein CTD PMID:30698894 vorinostat multiple interactions ISO RGD:1348437 6480464 vorinostat inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of MMP9 protein], vorinostat inhibits the reaction [TNF protein results in increased expression of MMP9 protein] CTD PMID:16377638 , PMID:27163855 vorinostat increases expression EXP 6480464 vorinostat results in increased expression of MMP9 mRNA CTD PMID:20060208 vorinostat decreases secretion ISO RGD:1348437 6480464 vorinostat results in decreased secretion of MMP9 protein CTD PMID:20421217 vorinostat decreases expression ISO RGD:1348437 6480464 vorinostat results in decreased expression of MMP9 mRNA, vorinostat results in decreased expression of MMP9 protein CTD PMID:19509267 , PMID:26238599 WIN 55212-2 decreases activity ISO RGD:1348437 6480464 Win 55212-2 results in decreased activity of MMP9 protein CTD PMID:30776504 wogonin multiple interactions EXP 6480464 wogonin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein] CTD PMID:14700523 wogonin multiple interactions ISO RGD:1348437 6480464 wogonin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein], wogonin results in decreased expression of and results in decreased activity of MMP9 protein CTD PMID:21295103 wortmannin multiple interactions EXP 6480464 wortmannin inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein] CTD PMID:20195827 wortmannin decreases activity ISO RGD:1348437 6480464 wortmannin results in decreased activity of MMP9 protein CTD PMID:22033475 wortmannin multiple interactions ISO RGD:1348437 6480464 wortmannin inhibits the reaction [fucoidan results in decreased expression of MMP9] more ... CTD PMID:22033475 more ... xanthohumol multiple interactions ISO RGD:1348437 6480464 xanthohumol results in decreased expression of and results in decreased activity of MMP9 protein CTD PMID:23562496 xanthohumol multiple interactions ISO RGD:731911 6480464 xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA] CTD PMID:23994090 xanthohumol decreases expression ISO RGD:1348437 6480464 xanthohumol results in decreased expression of MMP9 mRNA CTD PMID:23562496 Y-27632 multiple interactions ISO RGD:1348437 6480464 Y 27632 inhibits the reaction [4-cresol results in increased expression of MMP9 protein], Y 27632 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] CTD PMID:15728660 , PMID:30910523 Y-27632 decreases expression ISO RGD:1348437 6480464 [Y 27632 results in decreased expression of RHOA protein] which results in decreased expression of MMP9 protein CTD PMID:19896475 zafirlukast multiple interactions ISO RGD:1348437 6480464 zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 mRNA], zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein] CTD PMID:31816286 zerumbone decreases expression ISO RGD:1348437 6480464 zerumbone results in decreased expression of MMP9 mRNA CTD PMID:16007145 zerumbone multiple interactions ISO RGD:1348437 6480464 zerumbone analog results in decreased expression of and results in decreased secretion of MMP9 protein CTD PMID:28987329 zidovudine multiple interactions EXP 6480464 Zidovudine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] more ... CTD PMID:14662518 zileuton decreases expression EXP 6480464 zileuton results in decreased expression of MMP9 mRNA CTD PMID:19309543 zileuton decreases activity EXP 6480464 zileuton results in decreased activity of MMP9 protein CTD PMID:19309543 zinc atom affects binding ISO RGD:1348437 6480464 Zinc binds to MMP9 protein CTD PMID:17137715 zinc atom multiple interactions ISO RGD:731911 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA, TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA] CTD PMID:23503329 zinc atom multiple interactions EXP 6480464 [Zinc binds to Curcumin] inhibits the reaction [Acetic Acid results in increased expression of MMP9 mRNA] CTD PMID:23933360 zinc atom decreases expression ISO RGD:1348437 6480464 Zinc results in decreased expression of MMP9 mRNA CTD PMID:18316168 zinc atom multiple interactions ISO RGD:1348437 6480464 Zinc inhibits the reaction [TNF protein results in increased secretion of MMP9 protein] CTD PMID:16606632 zinc oxide increases secretion ISO RGD:1348437 6480464 Zinc Oxide results in increased secretion of MMP9 protein CTD PMID:23726862 zinc oxide multiple interactions ISO RGD:731911 6480464 Zinc Oxide analog promotes the reaction [OVAL protein results in increased expression of MMP9 protein] CTD PMID:25127755 zinc oxide increases activity ISO RGD:1348437 6480464 Zinc Oxide results in increased activity of MMP9 protein CTD PMID:23726862 zinc protoporphyrin multiple interactions ISO RGD:1348437 6480464 zinc protoporphyrin promotes the reaction [arsenic trioxide results in increased expression of MMP9 protein] CTD PMID:27829220 zinc protoporphyrin multiple interactions ISO RGD:731911 6480464 zinc protoporphyrin inhibits the reaction [fisetin results in decreased expression of MMP9 mRNA], zinc protoporphyrin inhibits the reaction [fisetin results in decreased expression of MMP9 protein] CTD PMID:30076913 zinc sulfate multiple interactions ISO RGD:1348437 6480464 Zinc Sulfate inhibits the reaction [TNF protein results in increased secretion of MMP9 protein] CTD PMID:16606632 zinc(0) affects binding ISO RGD:1348437 6480464 Zinc binds to MMP9 protein CTD PMID:17137715 zinc(0) multiple interactions ISO RGD:1348437 6480464 Zinc inhibits the reaction [TNF protein results in increased secretion of MMP9 protein] CTD PMID:16606632 zinc(0) decreases expression ISO RGD:1348437 6480464 Zinc results in decreased expression of MMP9 mRNA CTD PMID:18316168 zinc(0) multiple interactions EXP 6480464 [Zinc binds to Curcumin] inhibits the reaction [Acetic Acid results in increased expression of MMP9 mRNA] CTD PMID:23933360 zinc(0) multiple interactions ISO RGD:731911 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA, TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA] CTD PMID:23503329 zoledronic acid multiple interactions ISO RGD:731911 6480464 zoledronic acid results in decreased expression of and results in decreased activity of MMP9 protein CTD PMID:15343380
Gene-Chemical Interaction Annotations